Document:

exv10w3

  

Exhibit 10.3

GROUP LONG TERM DISABILITY REINSURANCE AGREEMENT

THIS AGREEMENT is between SAFECO LIFE INSURANCE COMPANY of Seattle, Washington
(hereinafter “Insurer”) and DUNCANSON & HOLT SERVICES,
INC., a Maine corporation, as
Managing Agent (hereinafter “Managing Agent”) for each of the participating reinsurers
collectively referred to in this Agreement as the American Disability Reinsurance
Underwriters Syndicate (ADRUS) and listed in Appendix A (hereinafter “Reinsurer”).

The Managing Agent represents and warrants that the Reinsurer has authorised the Managing
Agent to enter into, execute and deliver agreements of this sort on its behalf and to
exercise all of
its rights and platform all of its obligations under such agreements
of its behalf,
including but not
limited to, underwriting of policies, collection of premiums, and
management of claims in accordance with the terms of such agreements.
All performances required by and for the
Reinsurer under this Agreement shall be conducted through the Managing Agent.

In consideration of the mutual promises set forth below, the parties agree as follows:

ARTICLE
I. GENERAL PROVISIONS

The effective, date of this Agreement is January 1, 1999. On and after this date, one hundred
percent (100%) (hereinafter referred to as the “Reinsured Percentage”) of the Insurer’s
liability (hereinafter referred to as “Underlying Risk”) for the group long term disability
insurance policies written on or after January 1,1999 will be ceded to and reinsured by the
Reinsurer.

This Agreement replaces and supersedes Group Long Term Disability Monthly Income
Reinsurance Agreement which was effective April 1, 1979 between the Insurer and the
Reinsurer,
and all subsequent amendments thereto. With respect to in force policies, the Reinsured
Percentage for policies effective prior to January 1, 1999 and reinsured under the prior
Group
Long Term disability Monthly Income Reinsurance Agreement between the two parties shall be
one hundred percent(100%).

Other terms and, conditions of this Agreement are as follows:

	A)	 	For risks reinsured under this Agreement, the Insurer will use only those policy forms
which have been approved by the appropriate regulatory authorities. After the Reinsurer
has reviewed and approved copies of these forms, and insurance policies have been
accepted by the the Policyholder and administered in accordance with the terms of this
Agreement, the Reinsurer will be liable to the Insurer for the Reinsured Percentage in
accordance
with the provisions of the policies reinsured.

 

 

	B)	 	The Insurer, by executing this Agreement, represents that it is
licensed to do insurance
business in every state, district or territory of the United States, or the
District of
Columbia, in which it does business; and that it is licensed to write the
group health and
disability insurance policies which are the subject of this Agreement.
	 
	C)	 	This Agreement represents an exclusive reinsurance arrangement between the
parties for
long term disability business. All business quoted using rates provided by the
Reinsurer
shall be reinsured under this Agreement. In the event the Reinsurer declines to
accept any
policy, the Insurer may reinsure such policy with another reinsurer.
	 
	D)	 	Upon agreement of risk and benefits between Reinsurer and
Insurer, any increase in
benefit liability resulting from Insurer’s divergence from same
shall be borne by the
Insurer. The Reinsurer does not assume liability for any risk not agreed upon and
which is incurred as a result of errors, intentional or otherwise, in the
policy and/or certificate issued.

ARTICLE II. UNDERWRITING

	A)	 	Any reinsurance under this Agreement will be effected only
through the express written consent of the Reinsurer for each case submitted under any disability insurance
policy
covered by this Agreement. The Insurer will submit underwriting data to the
Reinsurer and the Reinsurer will inform the Insurer of its decision to accept
or reject liability. The
Reinsurer will make available to the Insurer the underwriting data prepared and used in
making its determination.
	 
	 	 	The Reinsurer has the right to approve individuals insured under any policy
as a condition of its acceptance of that policy. The Reinsurer may waive this
right for some or all policies
at any time.
	 
	B)	 	The Reinsurer shall keep and maintain appropriate records of evidence of insurability,
including but not limited to the policy, applications, certificates of coverage, medical
forms, and other evidence of insurability, for at least three (3)
years. Upon termination of
this Agreement, the Reinsure, will retain and Insurer shall have
access to such information for the later of three (3) years from termination date or the date the last active claim
ceases.
	 
	C)	 	Either the Insurer of the Reinsurer may, at any reasonable time during normal working
hours of the Insurer and upon provision of written notice fourteen (14) days in advance,
review and audit the records of the other party relating to business reinsured under this Agreement.

2

 

ARTICLE
III. FINANCIAL RESPONSIBILITIES AND TRANSACTIONS

	A)	 	The Insurer shall remit premium for reinsured group long term disability policies to
the
Reinsurer within ninety (90) days from the date on which premium is due to the Insurer.
The Insurer will follow all prudent procedures for premium collection and will notify
the Reinsurer of all reinsured policies for which premium is overdue by ninety (90)
days of the due date. The Reinsurer may assess an interest charge equal to the
interpolated seven (7) year value of five (5) year and ten (10) year United States
Treasury Bonds on premium overdue by more than ninety (90) days.
	 
	 	 	The Insurer will follow all prudent procedures for premium collection and will
notify the Reinsurer of all reinsured policies for which premium is
overdue by thirty (30) days of the due date. The Reinsurer may assess
an interest charge equal to the interpolated seven (7)
year value of five (5) year and ten (10) year United States Treasury Bonds on premium
overdue by more than thirty (30) days.
	 
	 	 	If the premium payment period for any policy comprising the Underlying Risk is other than
monthly, the parties to this Agreement shall determine, by mutual consent the proper
method of reporting, accounting, and transferring of balances.
	 
	 	 	For past due premiums on all reinsured policies for which premiums remain
due and unpaid for thirty (30) days following their due date, the Insurer shall
take appropriate action to terminate all prospective liability in accordance with
the policy provisions and shall institute its usual collection procedures. If the
Insurer fails to take appropriate action to terminate all prospective liability,
the Reinsurer reserves the right to terminate reinsurance of such ceded policies
for which premiums remain unpaid for thirty (30) days past their due date.
	 
	B)	 	For any business sold under this Agreement, the Reinsurer will specify the percentage
of premium to be paid to it for reinsurance of each policy at the time Reinsurer accepts
liability under the terms of the Underwriting Article of this Agreement.
	 
	C)	 	The liability of the Reinsurer shall begin simultaneously with the Reinsurer’s
acceptance of reinsurance for a long term disability
insurance policy, subject to the terms of this Agreement.
	 
	D)	 	The insurer is responsible for paying all premium taxes concerning any business covered by
this Agreement.
	 
	E)	 	Upon provision of written notice fourteen (14) days in
advance,
each party shall have the right, at any reasonable time during normal
working hours, to inspect, at the office of the other party all
non-proprietary, non-confidential and non-privileged books, records and
documents relating to policies reinsured under this Agreement.

3

 

	F)	 	If the Insurer fails to pay the consideration described in this Article, the
Reinsurer shall have

the right to terminate, from the date up to which the policy premiums have been paid,
its obligation for that portion of the Underlying Risk for which consideration is in arrears.
	 
	G)	 	The Reinsurer will be bound by the consideration it specifies for a particular
policy.
However, on any date that the Insurer has the right to terminate a policy or change
the
premium for said policy, the Reinsurer may, with sixty (60) days advance notice,
modify the
rate of consideration or terminate reinsurance on the policy. The Insurer shall
then be
bound by the modification.
	 
	H)	 	Reinstatement of the reinsurance on ceded policies which have been terminated
under any provision of this Article shall be at the Reinsurer’s discretion.
	 
	I)	 	Each party to this Agreement shall have the right to offset any balance(s), or
any other amounts due relating to this or related agreements. In the event of the
insolvency of a party to this Agreement, offsets shall only be allowed
in accordance with the Insolvency Article of this Agreement.

ARTICLE IV. CLAIMS

The
Insurer shall promptly transmit to the Reinsurer all claims, proofs of loss and
supplemental statements of disability submitted on a policy reinsured
hereunder. Upon receipt thereof
the Reinsurer will pay the claim and/or recommend other appropriate action. The Reinsurer will
not be liable for any claim received from the Insurer more than one year after this claim has
been received in the Insurer’s office. The Reinsurer may change the reinsurance rate, retroactive
to the last renewal date, if the receipt of a claim reported to the Reinsurer is more than one year
after receipt by the Insurer and if the timely receipt would have
caused a different reinsurance rate to be
charged.

	A)	 	All services will be performed in accordance with
Appendix B, the Claims Management
Agreement. This Agreement includes administrative procedures particular to the claims
management process and includes, but is not limited to. Authorization to Pay
Claims, Claim Administration Guidelines, Claim Data; Payment of
Benefits; Payment of
Claim Expenses; Right to Audit; and is mutually agreed to by the parties of this Agreement.
	 
	B)	 	The Reinsurer will undertake the defense of any suit, or portion of a suit, which
is based or alleged to be based on claims for benefits under group disability policies covered by this
Agreement where the claim is first commenced after the effective date
of this Agreement,
and the underlying policy is effective on or after the effective date of this
Agreement. Except as otherwise provided in this Agreement, choice of counsel and
management of any such suit, or portion of such suit, shall be agreed
upon by the Insurer
and the Reinsurer,
which will have the exclusive right to settle any such suit, when in its informed and good
faith opinion, it is appropriate to do so. The Insurer will cooperate with the Reinsurer in the
defense of such suits.

4

 

	C)	 	The Insurer and the Reinsurer will notify each other promptly of
any litigation brought
against it with respect to the policies covered by this Agreement.
	 
	D)	 	Claims for Extra-Contractual Amounts. “Extra-Contractual Amounts” are
amounts outside
of contractual benefits which may include, but are not necessarily limited to:
punitive,
exemplary, compensatory or consequential damages or plaintiff’s
litigation-related costs and
fees.

	 	i)	 	If extra-contractual amounts are awarded against the
Insurer solely as a result of the Reinsurer’s decision, action, delay or
failure to act, the Reinsurer shall pay one hundred percent (100%) of all
such amounts.
	 
	 	ii)	 	If extra-contractual amounts are awarded against the Insurer solely as a
result of Insurer’s decision, action, delay, or failure to act, the Reinsurer
shall have no (0%) percentage of liability for the payment of extra-contractual
amounts.
	 
	 	iii)	 	When extra-contractual amounts are awarded against the Insurer
 as a result of both the Reinsurer’s and the Insurer’s
decision, action, delay or failure to act, the parties
agree to share in the payment of any extra-contractual amounts.
	 
	 	iv)	 	To expedite the resolution of certain claims, amounts other than
policy benefits may be added to a claim settlement.

Allocation of responsibility for decisions, actions, delays, or failures to act shall be
determined by the parties’ agreement subsequent to good faith negotiation. Said
determination is solely for the purpose of efficient administration of this
Agreement and for determining who shall assume the costs in certain instances. If
agreement on such allocation cannot be reached, the matter shall be
addressed in
accordance with the Arbitration Article of this Agreement.

If any
portion of this subsection (D) is deemed to be illegal under
any law (decisional
or statutory) or regulation of any Federal, State or local government, insofar as it
applies to that area’s jurisdiction, then said portion is automatically terminated.

ARTICLE
V. RESERVE ADMINISTRATION

The
Reinsurer agrees to provide reserve reports on group long term disability
business under this Agreement to the Insurer in a form mutually acceptable to the
parties. Such reports shall be provided to Insurer within thirty (30) days after the end
of each calendar quarter.

ARTICLE
VI. DURATION, RECAPTURE AND TERMINATION

	A)	 	This Agreement shall govern the relationship of the parties until the liability of
the Reinsurer
with respect to all policies reinsured hereunder ceases. In accordance with the
provisions of this Article, this Agreement can be terminated by either party with respect to all
prospective

5

 

	 	 	acceptances. Termination of the group long term disability insurance exclusively shall not
occur when other lines of disability insurance are also written under this Agreement.
	 
	 	 	Any partial or complete prospective termination of this Agreement must be made in writing prior to
October 1st of each year. Termination shall occur on the desired effective date of
termination or ninety days from receipt of notice, whichever is later.
	 
	B)	 	After this Agreement has been inforce for more than one (1) year from the effective date, the
Insurer may decrease the Reinsured Percentage. The following schedule is the minimum Reinsured
Percentage for each disability policy in effect at the anniversary date of this Agreement.

	 	 	 	 	 
	Year 1 following notification
	 	 	75	%
	Year 2 Following notification
	 	 	75	%
	Year 3 following notification and thereafter
	 	 	50	%

	 	 	Notification must be received by the Reinsurer not later than October 1 of the year prior to the
intended change. The Reinsured Percentage will remain at current Reinsured Percentage absent any
notification. The change in Reinsured Percentage will occur at the next renewal date of the
underlying reinsured policy occurring after the anniversary of the change. Upon termination of this
Agreement, the Insurer may reduce the Reinsured Percentage to zero percent (0%) five (5) years from
the effective date of the termination. Notification must be provided 90 days in advance.
	 
	C)	 	The Reinsured Percentage governing any particular claim under a reinsured policy will be that
Reinsured Percentage in effect as of the date of disability.
	 
	D)	 	As of the date termination becomes effective Reinsurer will provide Insurer only with those
necessary claims and financial services required to manage any reinsured business.
	 
	F)	 	If Insurer becomes insolvent, as determined by the state regulatory agency, this Agreement will
terminate automatically as of the date of insolvency as to all prospective acceptances by the
Reinsurer. Liabilities already incurred by the Reinsurer will be administered in accordance with
the Insolvency Article of this Agreement.

ARTICLE VI. NON-TRANSFERABILITY OF AGREEMENT

Neither the Insurer nor the Reinsurer shall, without prior consent of the other, which shall not be
unreasonably withheld, sell, assign, transfer, or otherwise dispose of this Agreement, policies or
policy liabilities covered by this Agreement, or any interest in such Agreement, by voluntary or
involuntary act, by assumption agreement or otherwise, and any attempt to dispose of said
interests, without said consent, shall be null and void. Notwithstanding the foregoing, Insurer or
Reinsurer may arrange for a Third Party Administrator to perform some or all of the obligations
hereunder. So doing will not relieve the Insurer or Reinsurer from the obligations hereunder,

6

 

though, in the event that the Third
Party Administrator does not perform the obligations as stated
herein.

ARTICLE VII. PARTIES TO THIS AGREEMENT

	A)	 	This is an agreement solely between the Insurer and the Reinsurer. The acceptance of
reinsurance hereunder shall not create any right or legal relation whatever between the
Reinsurer and any of Insurer’s policyholders, beneficiaries, representatives, sales
representatives, employees or shareholders.

	B)	 	A failure or delay of either party to this Agreement to enforce any of the provisions
of this Agreement, or to exercise any option which is herein provided, shall in no way be
construed to be a waiver of such provision.

ARTICLE VIII. CONFIDENTIALITY

	A)	 	The Insurer and the Reinsurer may come into the possession or knowledge of
confidential and proprietary information of the other in fulfilling obligations under this
Agreement. Insurer and the Reinsurer agree to hold such confidential information in
strictest confidence and to take all reasonable steps to ensure that such confidential
information is not disclosed in any form by any means by each of them or by any of their
employees or associates to third parties of any kind, except by advance authorization.
“Confidential information” means any information which (1) is not generally available to
the public, or (2) has not been lawfully obtained by the parties prior to the date of
disclosure to it by the other, and includes but is not limited to:

	 	i)	 	Information or knowledge about each party’s products, processes,
services, finances, customers, research, computer programs, marketing and business
plans, claims management practices, and reserving methodology; and
	 
	 	ii)	 	Any medical and other personal, individually identifiable information
about people or business entities with whom the parties do business, including
customers, prospective customers, vendors, suppliers, individuals covered by
insurance plans, and each party’s producers and employees.

	B)	 	The Insurer and its agents, employees and representatives will not represent
themselves, in writing, as part of the Reinsurer, or refer, in
writing, to the Reinsurer in any policy forms or promotional materials, without the prior written consent of the
Reinsurer.

ARTICLE IX. INSOLVENCY

The Reinsurer agrees that all reinsurance under this Agreement shall be payable by the Reinsurer on
the basis of the liability of the Insurer under each policy reinsured under this Agreement.

7

 

without diminution because of the insolvency of the Insurer, and the Reinsurer assumes
liability for such reinsurance as of the effective dates of such policies. Any such payments by the
Reinsurer shall be made directly to the Insurer or to its liquidator, receiver, or statutory
successor. In the event of the insolvency of the Insurer, the liquidator, receiver or statutory
successor of the Insurer shall give written notice that a claim is pending against the Insurer
with respect to policies comprising the Underlying Risk within a reasonable time after such claim
is filed in the insolvency proceedings. While the claim is pending, the Reinsurer may investigate
such claim and interpose, at its own expense, in the proceeding where such claim is to be
adjudicated any defense or  defenses which it may deem available to the Insurer or its liquidator
or receiver or statutory successor. The expense thus incurred by the Reinsurer shall be
chargeable, subject to court approval, against the Insurer as part of the expenses of liquidation
to the extent of a proportionate share of the benefit which may accrue to the Insurer solely as a
result of the defense undertaken by the Reinsurer.

Where two or more reinsurers are involved and a majority of interest elect to defend a claim, the
expense will be apportioned in accordance with the terms of the reinsurance agreement as if the
expense had been incurred by the Insurer.

ARTICLE X. ARBITRATION

	A)	 	The parties explicitly agree that all differences, whether matters of fact, law or
mixed fact and law, which arise out of the interpretation or execution of this Agreement,
will be decided by arbitration except for those matters which are left to the sole
discretion of the Reinsurer or the Insurer under the terms of this Agreement. The parties
explicitly agree that arbitration shall be the sole and exclusive remedy for all such
differences, and that the arbitrators will determine the interpretation of this Agreement
in accordance with the usual business and reinsurance practices rather than strict
technicalities. Three neutral arbitrators will decide any differences. They must be active
or retried officers of life insurance companies other than the two parties to this Agreement
or any of their subsidiaries. In addition, the officers may not be former employees of the
two parties to this Agreement or any of their subsidiaries. In
addition, the officers may not be former
employees of the two parties to this Agreement or any of their subsidiaries. One of the arbitrators is to be appointed
by each party to this Agreement, and the two arbitrators will select a third. If the two are
not able to agree on a third, the choice will be left to the President of the Society of
Actuaries of its successor. The arbitration shall be in accordance with the Commercial
Arbitration Rules of the American Arbitration Association, or its successor and will take
place in Portland, Maine. This Agreement shall be deemed binding upon the arbitrators for
matters expressly agreed to herein. The arbitrators’ decision shall be by majority vote,
and no appeal shall be taken from it. The judgment rendered by the arbitrators may be
entered in any court having proper jurisdiction. Expenses and fees for the arbitrators
shall be shared by the Insurer and the Reinsurer in equal portions.

	B)	 	The arbitrators may award only contractual damages to either party. In no event may
extra contractual damages, including amounts available under any state or federal
Racketeer Influenced and Corrupt Organization Act (RICO), be awarded to either party under
this

8

 

	 	 	Agreement for breach of said agreement. However, the arbitrators may allocate responsibility for 1)
any extra-contractual amounts awarded against the Insurer, or 2) any amounts representing extra-contractual
damages in a settlement, between the Insurer and the Reinsurer as set forth
in the Claims Article of this Agreement.
	 
	C)	 	The procedures specified in this Article shall be the sole and exclusive procedures
for the resolution of disputes between the parties arising out of or relating to this
Agreement; provided, however, that a party may seek a preliminary injunction or other
preliminary judicial relief if in its judgment such action is necessary to avoid
irreparable damage. Despite such action the parties will continue to participate in good
faith in the procedures specified in this Article. All applicable statutes of limitation
shall be tolled while the procedures specified in this Article are pending. The parties
will take such action, if any, required to effectuate such tolling.
	 
	D)	 	Notwithstanding any other provision of this Article, in the event that either party
seek, consents to, or acquiesces in the appointment of, or otherwise becomes subject to,
any trustee, receiver, liquidator, or conservator (including any state insurance
regulatory agency acting in such a capacity), the other party shall not be obligated to
resolve any claim, dispute, or cause of action under this Agreement by arbitration and may
elect to bring any action with respect to such claim, dispute or cause of action in any
court of competent jurisdiction.

ARTICLE XI. YEAR 2000 COMPLIANCE

The Insurer and the Reinsurer each separately represents and warrants that it has established a written
project plan and budget to address Year 2000 issues, and that its plan includes:

	 	i)	 	conducting an inventory and assessment of Year 2000 impacts to its telecommunications
and information systems, related software and hardware, and its facilities (e.g.,
buildings and utilities);
	 
	 	ii)	 	conducting a review of the Year 2000 preparedness of its significant business
partners and suppliers;
	 
	 	iii)	 	correcting its Year 2000 problems and testing and validating its conversion efforts,
and
	 
	 	iv)	 	establishing contingency and avoidance plans.

Each party represents and warrants that all of its telecommunications and information systems and
related software and hardware have been found to be Year 2000 compliant, or will be made so on or
before December 31, 1999. The Insurer agrees to cooperate in good faith with the Reinsurer with
respect to Year 2000 issues by sharing information with the Reinsurer about the status and progress
of the Insurer’s Year 2000 compliance work and with respect to testing and validation, Reinsurer
agrees to do the same. For purposes of this section, “Year 2000
compliant” means: manages and manipulates data involving dates with full representation of year and century (i.e.

9

 

YYYYMMDD) both internally and externally to the Database, System or Application; follows standards
for acquisition, storage, presentation, and handling of dates including provisions for leap year
and leap centuries. This applies to data stored and retrieved, reports, screens, and data that is
sent or received.

ARTICLE XII. ERRORS AND OMISSIONS

Inadvertent and harmless delays, errors or omissions made in connection with this Agreement or any
transaction hereunder, except as otherwise stated in this Agreement, shall not relieve either party
from any liability which would have attached had such delay, error or omission not occurred,
provided that the fault is rectified as soon as possible after discovery.

ARTICLE XIII. APPLICABLE LAW

This Agreement is governed by the laws of the State of Maine.

ARTICLE XIV. MODIFICATION

	A)	 	This Agreement constitutes the entire understanding between the Reinsurer and the
Insurer. Neither party shall be bound by any other representation made before or after the
date of this agreement, unless it is made in writing signed by both parties and expresses
by its terms an intention to modify this Agreement.

	B)	 	In the event that any one or more of this provisions of the Agreement shall, for any
reason, be held to be invalid, illegal or unenforceable, the remaining provisions of this
Agreement shall be unimpaired.

IN WITNESS WHEREOF, the parties have caused this Agreement to be executed in duplicate by their
respective officers duly authorized so to do as of the date set forth above

	 	 	 	 	 	 	 	 	 	 	 
	DUNCANSON &
HOLT SERVICES,	 	 	 	SAFECO LIFE INSURANCE	 	 
	INC. ( Managing Agent of Reinsurer)	 	 	 	COMPANY (Insurer)	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	By

	 	/s/ Paul K. Fields
 

	 	 	 	By
	 	/s/ John P. Fenlason
 

	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	Title

	 	VP Finance
 

	 	 	 	Title
	 	Sr. Vice President
 

	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	Date

	 	8-30-99
 

	 	 	 	Date
	 	8-17-99
 

	 	 

	 	 	 	 	 	 	 	 	 	 	 
	/s/ Sharon Newton
	 	 	 	/s/ Joseph Allen Wymich	 	 	 	 	 	 
	 	 	 	 	 	 	 
	Witness

	 	 	 	 	 	Witness	 	 	 	 

10

 

APPENDIX A-20

AGREEMENT YEAR 1999

January 1,
1999 to December 31, 1999

Member
Reinsurers who have contracted with Duncanson & Holt Services, Inc., as Managing Agent
of ADRUS and their levels of participation are follows:

	 	 	 	 	 	 	 	 	 
		 	DOLLAR	 	PERCENTAGE
	MEMBER REINSURER	 	PARTICIPATION	 	PARTICIPATION
	Allianz Life Insurance Company
of North America
	 	$	30,000	 	 	 	100.00	%
	 
	 	 	 	 	 	 	 	 
	TOTAL AUTHORIZED PARTICIPATION
	 	$	30,000	 	 	 	100.00	%

11

 

Claims Management Agreement

Appendix B

I. Claims Management Services

In
satisfaction of its obligations to assist the Insurer with the processing of claims arising
under Policies Reinsured in
connection with the Group Long Term Disability Reinsurance Treaty
(“the Treaty”), the Reinsurer designates Claims Service
International, Inc. (“CST”) to perform claims management
services in connection with the Treaty as set forth herein. The
Insurer shall not be liable to CSI for the services rendered under
the Claims Management Agreement and shall not bear any of the
expenses incurred by CSI in connection with  CSI’ s performance of services hereunder, except as may be expressly set forth
herein. The obligation of CSI to perform administrative Service in
connection with
the Treaty shall continue until such time as all reinsured claims
have been paid,unless
other agreement is reached and becomes a written part of this Agreement.

II. Standard of Care

CSI will manage claims using the same standard of care, diligence and good faith which
Reinsurer exercises in the performance of its own business and shall be consistent with
prudent claim processing practices in the industry, in compliance with applicable laws.

III Licenses

CSI will maintain all necessary licenses to perform this Claims Management Agreement. CSI shall execute any documents
reasonably required by the Insurer in order for the Insurer to comply
with laws relating to the third party
administration of claims.

IV. Claims Administration Guidelines/Claims Data

The Insurer will direct all policyholders that insured individuals and their assignees must
provide notices of all reinsured disability claims, proofs of loss and any supplemental statements
of disability directly to CSI for processing. CSI will communicate with all parties involved in the claims
management process using the identity of “Claims Advisory
Agent” for the Insurer. CSI on behalf of the Reinsures, will use Insurer Long term
Disability (LTD)claims forms, as modified to name CSI as the Claims Advisory Agent.

12

 

CSI will provide the Insurer with copies of all responses to Department of Insurance (DOI)
complaints. The Insurer will not retain individual LTD claim files except for copies of
responses to DOI complaints. CSI will retain all individual LTD claims files and will store
all such files for a period of ten years after the closure of the file. CSI will destroy all
claims files in a manner to preserve confidentiality. Upon proper request, CSI shall provide
access to the books and records maintained by CSI for the purposes of examination, audit and
inspection by any insurance department which purports to exercise jurisdiction over the
business which is subject to the Treaty.

V.
Payment of Claims/Authorization to Pay Claims

Upon
receipt of claims, proofs of loss and/or supplemental statements of disability, CSI,
on behalf of the Reinsurer in accordance with Article IV of the Treaty, will pay the claim or
will take appropriate alternative action. The Insurer or the policyholder will provide to CSI
all necessary information to verify eligibility and premium
requirements, where such information has not already been provided to the
Reinsurer. CSI shall be responsible for mailing acknowledgment letters and claims denial
letters.

In the event that CSI determines that a claim should be denied, CSI will send to the claimant
a notice of denial within 10 business days of the determination. Any notice of denial will be
sent directly, to claimant and will state the reason for denial. Procedures for appeals are to
be. included in the letter to the claimant. A copy of the denial letter shall be forwarded to
the policyholder when applicable.

Beginning
January 1, 1999, CSI will process and pay all claims made against the
policies reinsured under this Treaty for the Insurer. In connection therewith, the Insurer
will provide to CSI signatory authority on a block of the Insurer drafts to be written
against a the Insurer bank account. CSI shall be responsible for mailing, at its expense, all
communications that are required to be mailed to claimants, including checks and EOBs.
Additionally Insurer.

CSI shall
pay each claim under polices reinsured under the Treaty within the
time period allowed by the state
in which the claimant resides. Before suspending any payments, CSI
Will send to claimant a letter, advising the claimant that
benefits will be suspended unless the claimant sends information which in the judgment of
CSI support the continued payment of benefits. A copy of this letter shall be forwarded to
the policyholder when applicable.

13

 

VI. Claims Expenses

All LTD claims expenses will paid by the Reinsurer. Normal claim expenses include, but are not
limited to, the following: medical records; Independent Medical Exams; vendor costs; claim
investigation and rehabilitation. It does not include salaries of either the Insurer’s or
Reinsurer’s employees.

VII. Right to Audit

At its discretion the Insurer, or its designated representative, has the right to conduct random
audits of LTD claims reinsured under the Treaty. Such audits shall be
conducted., by staff of
the Insurer, or its designated representative, at the expense of the Insurer and at the regular
locations of CSI and/or the Reinsurer during normal business hours. Access to all relevant. policy
information and case data regarding reinsured, claims shall be made available for audit
proceedings. The number of claims to be audited will be determined in the sole discretion of the
Insurer.

Results of audits by the Insurer shall be communicated to the Reinsurer in a verbal summary
followed by written documentation of the findings, including any irregularities or problems
identified.

VIII. Information Relating to Fraudulent Claims

CSI will provide to the Insurer, upon the Insurer’s request, a list of measures that CSI uses to
detect fraudulent claims.

IX. Responsibility of Reinsurer for Act of CSI.

Reinsure shall be responsible for all acts of CSI as if the Reinsure had itself performed said
acts.

The
signatures below constitute acceptance of the Claims Management Agreement by all
parties Nothing contained in the Claims Management Agreement shall
vary, alter or affect any of the terms or conditions of the Group
Long Term Disability Reinsurance Agreement.
The Claims Management Agreement may be revised only by changes agreed
to by both parties and documented in writing.

14

 

IN WITNESS WHEREOF, the parties have signed this Claims Management Agreement on the dates shown.

	 	 	 	 	 	 	 	 	 	 	 
	DUNCANSON & HOLT SERVICES,
INC. 
(Managing Agent of Reinsurer)	 	 	 	SAFECO LIFE INSURANCE
COMPANY 
(Insurer)	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	By

	 	/s/ Paul K. Fields
	 	 	 	By	 	/s/ John P. Fenlason	 	 
	 

	 	 
	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	Title

	 	 V P Finance
	 	 	 	Title
	 	Sr. Vice President	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	Date

	 	8/30/99
	 	 	 	Date
	 	8/17/99	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	/s/
Sharon Newton	 	 	 	/s/
Joseph Allen Wymich	 	 
	Witness	 	 	 	Witness	 	 

15

 

AMENDMENT NO. 1

TO THE

GROUP LONG TERM DISABILITY REINSURANCE TREATY

Bearing Effective Date January 1, 1999

THE AGREEMENT by and between SAFECO Life Insurance Company of Seattle, Washington (Insurer)
and DUNCANSON & HOLT SERVICES, INC. (Managing Agent for American Disability Reinsurance
Underwriters Syndicate, Reinsurer), is hereby modified as follows:

Article IV(E):
The Insurer or the Reinsurer may engage a Third-Party Administrator (TPA)
to manage claims under this Agreement after the effective date of this Amendment. Any
TPA arrangement will require the approval of both the Insurer and Reinsurer.

The effective date of the change described above is January 1,2000 for all group long
term disability policies effective prior to or on that date.

The signatures affixed hereto constitute acceptance of this Amendment by both parties. Nothing
contained herein shall be held to vary, alter, or affect any of the terms and conditions of
said Treaty other than as herein stated.

IN WITNESS WHEREOF, the parties have signed this Amendment in duplicate on the dates shown
below:

	 	 	 	 	 	 	 	 	 	 	 
	DUNCANSON & HOLT SERVICES,INC	 	SAFECO LIFE INSURANCE COMPANY  
	(Managing Agent of Reinsurer)	 	(Insurer)
	 
	 	 	 	 	 	 	 	 	 	 
	By:

	 	/s/ Paul K. Fields
	 	 	 	By:
	 	/s/ Scott Taylor	 	 
	 
	 	 	 	 	 	 
	(Signature)	 	 	 	(Signature)	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	V P Finance	 	 	 	Sr. V. P.	 	 
	 
	 	 	 	 	 	 
	(Title)	 	 	 	(Title)	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	10/17/00	 	 	 	10/24/00	 	 
	 
	 	 	 	 	 	 
	(Date)	 	 	 	(Date)	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	/s/  Sonia D. Davis	 	 	 	/s/  Betty Amundson	 	 
	 	 	 	 	 	 	 
	(Witness)	 	 	 	(Witness)	 	 

 

 

AMENDMENT

Amendment to the Group Long Term Disability Reinsurance Agreement between Symetra Life
Insurance Company (hereinafter the “Insurer”) of Redmond, Washington and Integrated
Disability Resources, Inc., a Connecticut corporation, as Managing Agent (hereinafter the
“managing agent”) for each of the participating reinsurers collectively referred to in
this Amendment as the American Disability Reinsurance Underwriters Syndicate (ADRUS):

Effective January 1, 2006, the parties hereby agree to amend the above-referenced
Reinsurance Agreement as follows:

Paragraph C) appearing in ARTICLE I. GENERAL PROVISIONS is amended to read as
follows:

	 	C)	 	All new pre-sale business which is quoted using rates provided by the
Reinsurer shall be reinsured under this Agreement. For new pre-sale business, this
Agreement represents a non-exclusive reinsurance arrangement between the parties.
	 
	 	 	 	This Agreement will continue to represent an exclusive reinsurance arrangement
between the parties with respect to renewals for Policies which are in force and
reinsured with Reinsurer as of January 1,2006. In the event the Reinsurer
declines to accept a renewal of any such policy, the Insurer may reinsure such
policy with another reinsurer.

All provisions of the Reinsurance Agreement not in conflict with the provisions
of this Amendment will continue unchanged.

IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be executed in
duplicate by the signatures of their duly authorized representatives as indicated below.

	 	 	 	 	 	 	 	 	 	 	 
	INTEGRATED DISABILITY
RESOURCES, INC.	 	 	 	SYMETRA LIFE INSURANCE COMPANY	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	By:

	 	/s/ Paul K. Fields
	 	 	 	By:
	 	/s/ Scott Taylor	 	 
	 

	 	 
	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	Name:

	 	Paul K. Fields
	 	 	 	Name:
	 	Scott Taylor	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	Title:

	 	CFO
	 	 	 	Title:
	 	SR V.P.	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	Date:

	 	4/27/2006
	 	 	 	Date:
	 	12/19/05	 	 

CDS on
behalf of Reliance [ILLEGIBLE]

 

 

AMENDMENT NO. 3

TO THE

GROUP LONG TERM DISABILITY REINSURANCE AGREEMENT

This Amendment No. 3 (the “Amendment”) is effective as of July 1, 2006 and is hereby made a part of
and incorporated into the Group Long Term Disability Reinsurance Agreement effective January 1,
1999 (the “Agreement”) by and between Symetra Life Insurance Company (formerly Safeco Life
Insurance Company) (hereinafter the “Insurer”) of Bellevue Washington and Reliance Standard Life
Insurance Company doing business as Custom Disability Solutions (successor to Integrated Disability
Resources, Inc., formerly Duncanson & Holt Services, Inc.), as Managing Agent (hereinafter the
“Managing Agent”) for each of the participating reinsurers collectively referred to in the
Reinsurance Agreement as the American Disability Reinsurance Underwriters Syndicate (“ADRUS”).
Capitalized terms not otherwise defined herein shall have the meaning ascribed to them in the
Agreement.

The parties agree that this Amendment No. 3 supersedes the prior Amendment No. 3 that was executed
by the parties effective July 1, 2006.

Intending to be legally bound, Insurer and Managing Agent agree to amend the Agreement as follows:

	1.	 	ARTICLE I. GENERAL PROVISIONS, Paragraph C is amended to read as follows:

	 	C)	 	All new business proposals which are quoted using rates provided by the Reinsurer
shall be reinsured under this Agreement, except for new business proposals produced:

	 	i)	 	by Meridian Benefits in the states of North Carolina, South Carolina and
Tennessee, or
	 
	 	ii)	 	from distribution channels and opportunities brought
to Insurer by other
reinsurance outlets, where discussions concerning such opportunities are not
initiated by the Insurer.

	 	 	 	Otherwise, this Agreement represents an exclusive reinsurance arrangement between the
parties with respect to new business proposals.
	 
	 	 	 	This Agreement will continue to represent an exclusive reinsurance arrangement between
the parties with respect to renewals for Policies which are in force and reinsured with
Reinsurer as of July 1, 2006. In the event the Reinsurer declines to accept a renewal of
any such policy, the Insurer may reinsure such policy with another reinsurer.

	2.	 	ARTICLE III. FINANCIAL RESPONSIBILITIES AND TRANSACTIONS, Section A),
first two paragraphs are amended to read as follows:
	 
	 	 	The Insurer shall remit premium for reinsured group long term disability policies to the
Reinsurer within ninety (90) days from the date on which premium is due to the Insurer.

1

 

	 	 	The Insurer will follow all prudent procedures for premium collection and will notify the
Reinsurer of all reinsured policies for which premium is overdue by ninety (90) days of the due
date.
	 
	 	 	The third and fourth paragraphs under Section A) remain unchanged by this Amendment.
	 
	3.	 	ARTICLE VI. DURATION, RECAPTURE AND TERMINATION is amended to read as follows:

ARTICLE VI. DURATION, TERMINATION AND RECAPTURE

	 	A)	 	Duration. This Agreement shall govern the relationship of the parties until the
liability of
the Reinsurer with respect to all policies reinsured under this Agreement ceases.
	 
	 	 	 	Insurer agrees to continue an ongoing active relationship with the Reinsurer for an initial
period ending December 31, 2007.
	 
	 	B)	 	Termination.

	 	(i)	 	Without Cause. Subject to Section A in this Article VI, either party may
terminate this Agreement with respect to all prospective acceptances, at any time by
providing ninety (90) days prior written notice to the other party.
	 
	 	(ii)	 	Insurer Insolvency. If Insurer becomes insolvent as determined by one or more
state regulatory agencies, this Agreement will terminate automatically as of the date
of insolvency as to all prospective acceptances. Liabilities already incurred by the
Reinsurer will be administered in accordance with the Insolvency Article of this
Agreement.
	 
	 	(iii)	 	Immediate Termination Rights. Notwithstanding the above, Insurer may
terminate this Agreement upon the occurrence of any of the following at any time by the
giving of fifteen (15) days prior written notice to the Managing Agent:

	 	a)	 	Either ADRUS or the Managing Agent ceases active underwriting operations;
	 
	 	b)	 	A State Insurance Department or other regulatory authority orders
ADRUS, or any then-participating member of ADRUS, to cease writing business;
	 
	 	c)	 	ADRUS, any then-participating member of ADRUS, or the Managing
Agent: 1) becomes insolvent, 2) is placed into liquidation or receivership, or 3)
has instituted against it proceedings for the appointment of a supervisor,
receiver, liquidator, rehabilitator, conservator or trustee in bankruptcy, or
other agent known by whatever name, to take possession of its assets or control
of its operations;

2

 

	 	d)	 	ADRUS or the Managing Agent enters into a definitive written agreement to
directly or indirectly assign its interests in this Agreement and liability for
obligations under this Agreement to another party without the Insurer’s prior
written consent;
	 	e)	 	The Managing Agent has entered into a definitive agreement to
sell substantially all of its assets without the Insurer’s prior written
consent; or
	 
	 	f)	 	ADRUS or the Managing Agent, has engaged in any of the following: 1) a pattern
or practice of failure by ADRUS or the Managing Agent to pay claims
on a timely basis, 2) a pattern or practice of failure by ADRUS or the Managing
Agent to abide by applicable federal or state laws, 3) a pattern or practice of
acts of bad faith conduct by ADRUS or the Managing Agent, or 4) a pattern or
practice of committing acts of negligent behavior by ADRUS or the Managing
Agent, in discharging the Reinsurer’s duties under this Agreement.

	 	C)	 	Recapture.
	 
	 	 	 	If the Insurer terminates the Agreement effective on January 1, 2008 or some other date in
2008, the recapture period shall, be three (3) years from the effective date of such
termination.
	 
	 	 	 	If the Insurer terminates the Agreement effective on or after January 1, 2009, the
recapture period shall be two (2) years from the effective date of such termination.
	 
	 	 	 	Recapture through any means will include 100% of the risk for the policies unless other
terms are agreed to by the Insurer and Reinsurer.
	 
	 	D)	 	The Reinsured Percentage governing any claim under a reinsured policy will be
that Reinsured Percentage in effect as of the date of disability.
	 
	 	E)	 	As of the date termination of the Agreement becomes effective, Reinsurer will provide
Insurer only with those necessary claim and financial services required to manage any
reinsured business. Upon termination, Reinsurer will utilize renewal methods, tools and
procedures which are consistent with those in use for renewals generally within Reinsurer’s
overall block of business at the time Insurer’s policies are
being renewed.

	 	 	4. The Agreement is amended by the addition of the following Article, which is applicable to
ADRUS members for all ADRUS agreement years effective on or after July 1, 2006.

ARTICLE XV. COLLATERAL REQUIREMENTS

	 	 	If the amount of capital and surplus of any ADRUS member has been reduced by 50% or more of the
amount of capital and surplus as stated in such ADRUS member’s most recent prior annual
statutory statement filed with its state of domicile, such ADRUS member shall deposit in trust
with a trustee (which shall not be an affiliate of such ADRUS
member), and thereafter at all
times maintain in such trust, assets at least equal in value to such ADRUS member’s
proportionate amount of the reserves required to be maintained from time to time

3

 

by
ADRUS under sound actuarial principles and accepted statutory accounting practices,
with respect to reserves required for liabilities incurred by ADRUS members under this
Agreement on or after July 1, 2006.

Such ADRUS member may alternatively post a letter of credit to satisfy such obligations. The
trust or letter of credit arrangements, and all documentation relating thereto, must be
satisfactory in form and substance to Insurer in its good faith discretion. The trust shall be
terminated and the assets returned to the ADRUS member, or the letter of credit returned for
cancellation, if the ADRUS member’s amount of capital and surplus increases by 10% of the amount
of capital and surplus as stated in such ADRUS member’s most recent prior annual statutory
statement filed with its state of domicile.

The
parties acknowledge that the collateral obligations under this provision predicated upon a
reduction in surplus shall not be applicable if the ADRUS member has already provided collateral
or taken other lawful actions that allow Insurer to receive full reserve credit with respect to
the reinsurance ceded under this Agreement.

All provisions of the Agreement not in conflict with the provisions of this Amendment will
continue unchanged.

IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be executed in duplicate
by the signatures of their duly authorized representatives as indicated below.

	 	 	 	 	 	 	 	 	 	 	 
	CUSTOM DISABILITY
SOLUTIONS,

Managing Agent of Reinsurer	 	 	 	SYMETRA LIFE INSURANCE COMPANY	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	By:

	 	/s/ Paul K. Fields
	 	 	 	By:
	 	/s/ Michael Fry	 	 
	 

	 	 
	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	Name:

	 	Paul K. Fields
	 	 	 	Name:
	 	Michael Fry	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	Title:

	 	CFO
	 	 	 	Title:
	 	V P	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	Date:

	 	8/16/2006
	 	 	 	Date:
	 	8/17/2006	 	 

4

 

AMENDMENT NO. 4

TO THE

GROUP LONG TERM DISABILITY REINSURANCE AGREEMENT

This Amendment No. 4 (“Amendment”) is hereby made a part of and incorporated into the Group
Long Term Disability Reinsurance Agreement which was effective January 1, 1999 (“Agreement”)
by and between Symetra Life Insurance Company (formerly Safeco Life Insurance Company)
(“Insurer”) of Bellevue, Washington and Reliance Standard Life Insurance Company doing
business as Custom Disability Solutions (successor to Integrated Disability Resources, Inc.,
formerly Duncanson & Holt Services, Inc.), as Managing Agent (“Managing Agent”) for each of
the participating reinsurers collectively referred to in the Agreement as the American
Disability Reinsurance Underwriters Syndicate (“ADRUS”). Capitalized terms not otherwise
defined herein shall have the meaning ascribed to them in the Agreement.

Intending to be legally bound, Insurer and Managing Agent agree to amend the Agreement as
follows:

Effective January 1, 1999, Appendix A-20 appearing in the Agreement is amended to read as
follows:

APPENDIX A

AGREEMENT YEAR 1999

January 1,
1999 to December 31, 1999

Member Reinsurers who have contracted with Duncanson & Holt Services, Inc. as Managing
Agent of ADRUS and their levels of participation are as follows:

	 	 	 	 	 	 	 	 	 
	 	 	DOLLAR	 	PERCENTAGE
	MEMBER REINSURER[S]	 	PARTICIPATION	 	PARTICIPATION
	UNUM Life Insurance Company of America
	 	$	30,000	 	 	 	100	%
	 
	 	 	 	 	 	 	 	 
	TOTAL AUTHORIZED PARTICIPATION
	 	$	30,000	 	 	 	100	%

1

 

IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be executed in duplicate
by the signatures of their duly authorized representatives as indicated below.

	 	 	 	 	 	 	 	 	 	 	 
	CUSTOM DISABILITY
SOLUTIONS,

Managing Agent of Reinsurer	 	 	 	SYMETRA LIFE INSURANCE COMPANY	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	By:

	 	/s/ Paul K. Fields
	 	 	 	By:
	 	/s/ David C. Fry	 	 
	 

	 	 
	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	Name:

	 	Paul K. Fields
	 	 	 	Name:
	 	David C. Fry	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	Title:

	 	CFO
	 	 	 	Title:
	 	Senior Actuary & AVP	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	Date:

	 	12/7/2006
	 	 	 	Date:
	 	12/8/2006	 	 

2

 

AMENDMENT 5

This Amendment No. 5 (“Amendment”) is hereby made a part of and incorporated into the Group
Long Term Disability Reinsurance Agreement effective January 1, 1999 (“Agreement”) by and between
Symetra Life Insurance Company (hereinafter the “Insurer”) of Bellevue, Washington and Reliance
Standard Life Insurance Company doing business as Custom Disability Solutions, as Managing Agent
(hereinafter the “Managing Agent”) for each of the participating reinsurers collectively referred
to in the Reinsurance Agreement as the American Disability Reinsurance Underwriters Syndicate
(ADRUS). Capitalized terms not otherwise defined herein shall have the meaning ascribed to them in
the Agreement.

Effective September 1, 2008, Insurer and Managing Agent agree to amend the Agreement as
follows:

ARTICLE 1. GENERAL PROVISIONS, Paragraph C) is amended to read as follows:

	 	C)	 	All new pre-sale business which is quoted using rates provided by the Reinsurer shall be
reinsured under this Agreement, except for new pre-sale business produced from distribution
channels and opportunities brought to Insurer by other reinsurance outlets, where discussions
concerning such opportunities are not initiated by the Insurer.
	 
	 	 	 	Otherwise, this Agreement represents an exclusive reinsurance arrangement between the
parties with respect to new pre-sale business.
	 
	 	 	 	This Agreement will continue to represent an exclusive reinsurance arrangement
between the parties with respect to renewals for Policies that are in force and
reinsured with Reinsurer as of July 1, 2006. In the event the Reinsurer declines to
accept a renewal of any such policy, the Insurer may reinsure such policy with another
reinsurer.

All provisions of the Agreement not in conflict with the provisions of this Amendment will
continue unchanged.

IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be executed in duplicate by
the signatures of their duly authorized representatives as indicated below.

	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	CUSTOM DISABILITY SOLUTIONS	 	 	 	SYMETRA LIFE INSURANCE COMPANY
	 
	 	 	 	 	 	 	 	 
	By:

	 	/s/ Paul K. Fields
	 	 	 	By:
	 	/s/ Marcus Wright
	 

	 	 
	 	 	 	 	 	 

	 	 	 	 	 	 	 	 	 
	Name:

	 	Paul K. Fields
	 	 
	 	Name:
	 	Marcus Wright
	 

	 	 
	 	 	 	 	 	 

	 	 	 	 	 	 	 	 	 
	Title:

	 	CFO
	 	 
	 	Title:
	 	Group Operations Director, AVP
	 

	 	 
	 	 	 	 	 	 

	 	 	 	 	 	 	 	 	 
	Date:

	 	9/26/2008
	 	 
	 	Date:
	 	September 17, 2008
	 

	 	 
	 	 	 	 	 	 

 

APPENDIX A-l

AGREEMENT YEAR 2000

January 1, 2000 to December 31, 2000

Member Reinsurers who have contracted with Duncanson & Holt Services, Inc. as Managing Agent of
ADRUS and their levels of participation are as follows:

	 	 	 	 	 	 	 	 	 
	 	 	DOLLAR	 	PERCENTAGE
	MEMBER REINSURER	 	PARTICIPATION	 	PARTICIPATION
	UNUM Life Insurance Company of America
	 	$	30,000	 	 	 	100.0	%
	 
	 	 	 	 	 	 	 	 
	TOTAL AUTHORIZED
PARTICIPATION
	 	$	30,000	 	 	 	100.0	%

1

 

APPENDIX A-2

AGREEMENT YEAR 2001

January 1, 2001 to December 31, 2001

Member Reinsurers who have contracted with Duncanson & Holt Services, Inc. as Managing Agent of
ADRUS and their levels of participation are as follows:

	 	 	 	 	 	 	 	 	 
	 	 	DOLLAR	 	PERCENTAGE
	MEMBER REINSURER	 	PARTICIPATION	 	PARTICIPATION
	UNUM Life
Insurance Company of America
	 	$	30,000	 	 	 	100.0	%
	 
	 	 	 	 	 	 	 	 
	TOTAL AUTHORIZED
PARTICIPATION
	 	$	30,000	 	 	 	100.0	%

2

 

APPENDIX A-3

AGREEMENT YEAR 2002

January 1, 2002 to December 31, 2002

Member
Reinsurers who have contracted with Integrated Disability Resources, Inc. as Managing Agent
of ADRUS and their levels of participation are as follows:

	 	 	 	 	 	 	 	 	 
		 	DOLLAR	 	PERCENTAGE
	MEMBER REINSURER	 	PARTICIPATION	 	PARTICIPATION
	UNUM Life
Insurance Company of America
	 	$	30,000	 	 	 	100.0	%
	 
	 	 	 	 	 	 	 	 
	TOTAL AUTHORIZED
PARTICIPATION
	 	$	30,000	 	 	 	100.0	%

3

 

APPENDIX A-4

AGREEMENT YEAR 2003

January 1, 2003 to December 31, 2003

Member Reinsurers who have contracted with Integrated Disability Resources, Inc. as Managing Agent
of ADRUS and their levels of participation are as follows:

	 	 	 	 	 	 	 	 	 
		 	DOLLAR	 	PERCENTAGE
	MEMBER REINSURER	 	PARTICIPATION	 	PARTICIPATION
	UNUM Life
Insurance Company of America
	 	$	30,000	 	 	 	100.0	%
	 
	 	 	 	 	 	 	 	 
	TOTAL AUTHORIZED
PARTICIPATION
	 	$	30,000	 	 	 	100.0	%

4

 

APPENDIX A-5

AGREEMENT YEAR 2004

January 1, 2004 to December 31, 2004

Member Reinsurers who have contracted with Integrated Disability Resources, Inc. as Managing Agent
of ADRUS and their levels of participation are as follows:

	 	 	 	 	 	 	 	 	 
		 	DOLLAR	 	PERCENTAGE
	MEMBER REINSURER	 	PARTICIPATION	 	PARTICIPATION
	UNUM Life
Insurance Company of America
	 	$	30,000	 	 	 	100.0	%
	 
	 	 	 	 	 	 	 	 
	TOTAL AUTHORIZED
PARTICIPATION
	 	$	30,000	 	 	 	100.0	%

5

 

APPENDIX A-6

AGREEMENT YEAR 2005

January 1, 2005 to December 31, 2005

Member Reinsurers who have contracted with Integrated Disability Resources, Inc. as Managing Agent
of ADRUS and their levels of participation are as follows:

	 	 	 	 	 	 	 	 	 
		 	DOLLAR	 	PERCENTAGE
	MEMBER REINSURER	 	PARTICIPATION	 	PARTICIPATION
	UNUM Life
Insurance Company of America
	 	$	30,000	 	 	 	100.0	%
	 
	 	 	 	 	 	 	 	 
	TOTAL AUTHORIZED
PARTICIPATION
	 	$	30,000	 	 	 	100.0	%

6

 

APPENDIX A-7

AGREEMENT YEAR 2006

January 1, 2006 to December 31, 2006

Member Reinsurers who have contracted with Custom Disability Solutions as Managing Agent of ADRUS
and their levels of participation are as follows:

	 	 	 	 	 	 	 	 	 
		 	DOLLAR	 	PERCENTAGE
	
MEMBER REINSURER	 	PARTICIPATION	 	PARTICIPATION
	Reliance
Standard Life Insurance Company
	 	$	30,000	 	 	 	100.0	%
	 
	 	 	 	 	 	 	 	 
	TOTAL AUTHORIZED
PARTICIPATION
	 	$	30,000	 	 	 	100.0	%

7

 

APPENDIX A-8

AGREEMENT YEAR 2007

January 1, 2007 to December 31, 2007

Member Reinsurers who have contracted with Custom Disability Solutions as Managing Agent of ADRUS
and their levels of participation are as follows:

	 	 	 	 	 	 	 	 	 
	MEMBER	 	DOLLAR	 	PERCENTAGE
	REINSURER	 	PARTICIPATION	 	PARTICIPATION
	Reliance Standard Life
Insurance Company
	 	$	30,000	 	 	 	100.0	%
	TOTAL AUTHORIZED
PARTICIPATION
	 	$	30,000	 	 	 	100.0	%

8

 

APPENDIX A-9

AGREEMENT YEAR 2008

January 1, 2008 to December 31, 2008

Member Reinsurers who have contracted with Custom Disability Solutions as Managing Agent of ADRUS
and their levels of participation are as follows:

	 	 	 	 	 	 	 	 	 
	MEMBER	 	DOLLAR	 	PERCENTAGE
	REINSURER	 	PARTICIPATION	 	PARTICIPATION
	Reliance Standard Life
Insurance Company
	 	$	30,000	 	 	 	100.0	%
	TOTAL AUTHORIZED
PARTICIPATION
	 	$	30,000	 	 	 	100.0	%

9

 

APPENDIX A-10

AGREEMENT YEAR 2009

January 1, 2009 to December 31, 2009

Member Reinsurers who have contracted with Custom Disability Solutions as Managing Agent of ADRUS
and their levels of participation are as follows:

	 	 	 	 	 	 	 	 	 
	MEMBER	 	DOLLAR	 	PERCENTAGE
	REINSURER	 	PARTICIPATION	 	PARTICIPATION
	Reliance Standard Life
Insurance Company
	 	$	30,000	 	 	 	100.0	%
	TOTAL AUTHORIZED
PARTICIPATION
	 	$	30,000	 	 	 	100.0	%

10

 

APPENDIX A-11

AGREEMENT YEAR 2010

January 1, 2010 to December 31, 2010

Member Reinsurers who has contracted with Custom Disability Solutions as Managing Agent of ADRUS
and their levels of participation are as follows:

	 	 	 	 	 	 	 	 	 
	 	 	Dollar	 	 	Percentage	 
	Reinsurer	 	Participation	 	 	Participation	 
	 
	 	 	 	 	 	 	 	 
	Reliance Standard Life Insurance Company
	 	$	30,000	 	 	 	100	%
	 
	 	 	 	 	 	 	 	 
	TOTAL AUTHORIZED PARTICIPATION
	 	$	30,000	 	 	 	100	%

11exv10w1

Exhibit 10.1

STANDBY EQUITY DISTRIBUTION AGREEMENT

     THIS AGREEMENT dated as of November 10, 2010 (this “Agreement”) between YA GLOBAL
MASTER SPV LTD., a Cayman Islands exempt limited partnership (the “Investor”), and
BANCTRUST FINANCIAL GROUP, INC., a corporation organized and existing under the laws of the State
of Alabama (the “Company”).

     WHEREAS, the parties desire that, upon the terms and subject to the conditions contained
herein, the Company may issue and sell to the Investor for resale to the public, from time to time
as provided herein, and the Investor will purchase from the Company up to $15,000,000 of the
Company’s common stock, par value $.01 per share (the “Common Stock”); and

     WHEREAS, the offer and sale of the shares of Common Stock issuable hereunder have been
registered by the Company on a registration statement on Form S-3 (File No. 333-153871) filed with
the United States Securities and Exchange Commission (the “SEC”), which has been declared
effective by the SEC under the Securities Act of 1933, as amended, and the rules and regulations
promulgated thereunder (the “Securities Act”).

     NOW, THEREFORE, in consideration of the premises and other good and valuable consideration,
the parties hereto intending to be legally bound, agree as follows:

Article I. Certain Definitions

Section 1.01 “Accredited Investor” shall have the meaning set forth in Section 3.07.

Section 1.02 “Additional Shares” shall have the meaning set forth in Section 2.01(e).

Section 1.03 “Advance” shall mean the portion of the Commitment Amount requested by the
Company in an Advance Notice.

Section 1.04 “Advance Notice” shall mean a written notice in the form of Exhibit A
attached hereto to the Investor executed by an officer of the Company and setting forth the Advance
amount that the Company requests from the Investor.

Section 1.05 “Advance Notice Date” shall mean each date the Company delivers (in accordance
with Section 2.01(a)) to the Investor an Advance Notice requiring the Investor to advance funds to
the Company, subject to the terms of this Agreement.

Section 1.06 “Advance Settlement Date” shall mean the 3rd Trading Day after the relevant
Pricing Period, or such earlier day as may be available for settlement.

Section 1.07 “Articles of Incorporation” shall have the meaning set forth in Section 4.06.

Section 1.08 “Base Prospectus” shall mean the Company’s prospectus included in the
Registration Statement.

 

 

Section 1.09 “BHC Act” shall mean the Bank Holding Company Act of 1956, as amended.

Section 1.10 “By-laws” shall have the meaning set forth in Section 4.06.

Section 1.11 “CIBC Act” shall mean the Change in Bank Control Act of 1978, as amended.

Section 1.12 “Commitment Amount” shall mean the aggregate amount of up to $15,000,000,
which the Investor has agreed to provide to the Company in order to purchase the Company’s Common
Stock pursuant to the terms and conditions of this Agreement; provided that, the
Company shall not effect any sales under this Agreement and the Investor shall not have the
obligation to purchase shares of Common Stock under this Agreement to the extent that after giving
effect to such purchase and sale the aggregate number of shares of Common Stock issued under this
Agreement would exceed 19.9% of the outstanding shares of Common Stock as of the date of this
Agreement) except that such limitation shall not apply in the event that the Company (i) obtains
the approval of its stockholders as required by the applicable rules of the Principal Market for
the Common Stock for issuances of Common Stock in excess of such amount or (ii) obtains a written
opinion from outside counsel to the Company that such approval is not required, which opinion shall
be reasonably satisfactory to the Investor.

Section 1.13 “Commitment Period” shall mean the period commencing on the Effective Date,
and expiring upon the termination of this Agreement in accordance with Section 10.02.

Section 1.14 “Common Stock” shall have the meaning set forth in the recitals of this
Agreement.

Section 1.15 “Company Financial Advisor” shall mean Burke Capital Group, a division of
Morgan Keegan & Co., Inc.

Section 1.16 “Company Minimum Price” shall mean a minimum acceptable price indicated by the
Company in connection with an Advance.

Section 1.17 “Company Periodic Report Date” shall have the meaning set forth in Section
6.11.

Section 1.18 “Condition Satisfaction Date” shall have the meaning set forth in Article VII.

Section 1.19 “Consolidation Event” shall have the meaning set forth in Section 6.06.

Section 1.20 “Effective Date” shall mean the date hereof.

Section 1.21 “Environmental Laws” shall have the meaning set forth in Section 4.11.

Section 1.22 “Exchange Act” shall mean the Securities Exchange Act of 1934, as amended, and
the rules and regulations promulgated thereunder.

Section 1.23 “Excluded Day” shall have the meaning set forth in Section 2.01(e).

Section 1.24 “Initial Disclosure” shall have the meaning set forth in Section 6.13.

2

 

Section 1.25 “Market Price” shall mean the lowest daily VWAP of the Common Stock during the
relevant Pricing Period which is greater than the Minimum Market Price.

Section 1.26 “Material Adverse Effect” shall mean any condition, circumstance, or situation
that has resulted in, or would reasonably be expected to result in (i) a material adverse effect on
the legality, validity or enforceability of this Agreement, (ii) a material adverse effect on the
results of operations, assets, business or condition (financial or otherwise) of the Company and
its subsidiaries, taken as a whole, or (iii) a material adverse effect on the Company’s ability to
perform in any material respect on a timely basis its obligations under this Agreement.

Section 1.27 “Maximum Advance Amount” shall be $250,000, or such other amount as may be
agreed upon by the mutual consent of the parties.

Section 1.28 “Minimum Acceptable Price” shall mean, for each Advance, (i) the Company
Minimum Price or (ii) if issuing Shares for a Purchase Price less than the TARP Minimum Price would
cause an adjustment to the exercise price for the TARP Warrants, the greater of the Company Minimum
Price and the TARP Minimum Price for such Advance.

Section 1.29 “Minimum Market Price” shall mean the product obtained by multiplying the
Minimum Acceptable Price by 1.042.

Section 1.30 “Net Advance Amount” shall mean the amount of an Advance (in each case as
reduced, if necessary, pursuant to Section 2.01(c), Section 2.01(d) or Section 2.01(e) and as
increased, if necessary, by the purchase price paid for any Additional Shares).

Section 1.31 “Ownership Limitation” shall have the meaning set forth in Section 2.01(a).

Section 1.32 “Person” shall mean an individual, a corporation, a partnership, an
association, a trust or other entity or organization, including a government or political
subdivision or an agency or instrumentality thereof.

Section 1.33 “Preferred Stock” shall have the meaning set forth in Section 4.06.

Section 1.34 “Pricing Period” shall mean the 5 consecutive Trading Days after the Advance
Notice Date.

Section 1.35 “Principal Market” shall mean the Nasdaq Global Select Market, the Nasdaq
Global Market, the Nasdaq Capital Market, the NYSE Euronext or the New York Stock Exchange,
whichever is at the time the principal trading exchange or market for the Common Stock.

Section 1.36 “Prospectus” shall mean the Base Prospectus, as supplemented by any Prospectus
Supplement.

Section 1.37 “Prospectus Supplement” shall mean any prospectus supplement to the Base
Prospectus filed with the SEC pursuant to Rule 424(b) under the Securities Act, including, without
limitation, the Prospectus Supplement required pursuant to Section 6.04 hereof.

3

 

Section 1.38 “Purchase Price” shall be set at 96% of the Market Price during the Pricing
Period.

Section 1.39 “Registration Limitation” shall have the meaning set forth in Section 2.01(a).

Section 1.40 “Registration Statement” shall mean the Company’s shelf registration statement
filed by the Company with the SEC under the Securities Act on Form S-3 (Registration Number
333-153871), with respect to Common Stock, Preferred Stock, rights and warrants to be offered and
sold by the Company, as such Registration Statement may be amended and supplemented from time to
time and including any information deemed to be a part thereof pursuant to Rule 430B under the
Securities Act and any additional or successor shelf registration statement filed by the Company
with the SEC under the Securities Act on a form promulgated by the SEC for which the Company then
qualifies and which form shall be available for the registration of the sale of Shares to the
Investor.

Section 1.41 “Registration Statement Amendment Date” shall have the meaning set forth in
Section 6.11.

Section 1.42 “Renewal Deadline” shall have the meaning set forth in Section 6.01.

Section 1.43 “SEC” shall have the meaning set forth in the recitals of this Agreement.

Section 1.44 “SEC Documents” shall have the meaning set forth in Section 4.03.

Section 1.45 “SEC Filings” shall have the meaning set forth in the first paragraph of
Article IV.

Section 1.46 “Securities Act” shall have the meaning set forth in the recitals of this
Agreement.

Section 1.47 “Settlement Document” shall have the meaning set forth in Section 2.02(a).

Section 1.48 “Shares” shall mean the shares of Common Stock to be issued from time to time
hereunder pursuant to Advances.

Section 1.49 “TARP Minimum Price” shall mean 90% of the last reported sale price regular
way as reported by Bloomberg L.P. on a Trading Day from 9:30 a.m. (New York City time) to 4:00 p.m.
New York City time on the last Trading Day of the applicable Pricing Period.

Section 1.50 “TARP Warrants” shall mean the warrant to purchase up to 730,994 shares of
Common Stock issued to the United States Department of The Treasury under the Troubled Asset Relief
Program Capital Purchase Program on December 19, 2008.

Section 1.51 “Trading Day” shall mean any day during which the Principal Market shall be
open for business.

Section 1.52 “VWAP” shall mean, for any Trading Day, the daily volume weighted average
price of the Common Stock for such date on the Principal Market as reported by Bloomberg L.P.

4

 

(based on a Trading Day from 9:30 a.m. (New York City time) to 4:00 p.m. (New York City time)).

Article II. Advances

Section 2.01 Advances; Mechanics. On the basis of the representations, warranties and
agreements herein contained, but subject to the terms and conditions herein, the Company, at its
sole and exclusive option, may, from time to time, issue and sell to the Investor, and the Investor
shall purchase from the Company, shares of Common Stock on the following terms:

	 	(a)	 	Advance Notice. At any time during the Commitment Period, the Company may
require the Investor to purchase shares of Common Stock by delivering an Advance Notice to
the Investor, subject to the conditions set forth in Article VII; provided,
however, that (i) the amount for each Advance as designated by the Company in the
applicable Advance Notice shall not be more than the Maximum Advance Amount, (ii) the
aggregate amount of all Advances pursuant to this Agreement shall not exceed the Commitment
Amount, (iii) in no event shall the number of shares of Common Stock issuable to the
Investor pursuant to an Advance cause the aggregate number of shares of Common Stock
beneficially owned (as calculated pursuant to Section 13(d) of the Exchange Act) by the
Investor and its affiliates to exceed 4.9% of the Company’s then outstanding Common Stock
(the “Ownership Limitation”) and (iv) in no event shall the aggregate offering
price or number of Shares, as the case may be, exceed the aggregate offering price or
number of Shares, as the case may be, available for issuance under the Registration
Statement (the “Registration Limitation”). The Company acknowledges that the
Investor may sell shares of the Company’s Common Stock corresponding with a particular
Advance Notice after the Advance Notice is received by the Investor, provided such
sale complies with all applicable laws.
	 
	 	(b)	 	Date of Delivery of Advance Notice. Advance Notices shall be delivered in
accordance with the instructions set forth on the bottom of Exhibit A or such other
instructions that the Investor may provide to the Company. An Advance Notice shall be
deemed delivered on (i) the Trading Day it is received by the Investor if such notice is
received prior to 5:00 pm Eastern Time, or (ii) the immediately succeeding Trading Day if
it is received after 5:00 pm Eastern Time on a Trading Day or at any time on a day which is
not a Trading Day. No Advance Notice may be deemed delivered on a day that is not a
Trading Day. The Company acknowledges and agrees that the Investor shall be entitled to
treat any email it receives purporting to be an Advance Notice from officers whose email
addresses are identified by the Company as a duly executed and authorized Advance Notice
from the Company. The Investor shall promptly confirm the receipt of any Advance Notice
delivered via email after such email is opened by replying to the sender of such email.
Any Advance Notice delivered by email shall be deemed received by the Investor only after
the Investor has sent such reply confirming receipt.
	 
	 	(c)	 	Ownership Limitation. In connection with each Advance Notice delivered by the
Company, any portion of an Advance that would cause the Investor to exceed the Ownership
Limitation shall automatically be withdrawn.

5

 

	 	(d)	 	Registration Limitation. In connection with each Advance Notice, any portion
of an Advance that would cause the aggregate offering price to exceed the Registration
Limitation shall automatically be deemed to be withdrawn by the Company with no further
action required by the Company. At the Company’s request from time to time, the Investor
shall report to the Company the total amount of Shares offered and sold pursuant to this
Agreement and the portion of the total Commitment Amount remaining.
	 
	 	(e)	 	Minimum Market Price Adjustment. The amount of the Advance set forth in an
Advance Notice shall automatically be reduced by 20% for each Trading Day during the
Pricing Period that the VWAP of the Common Stock is below the Minimum Market Price (each
such day, an “Excluded Day”). The number of shares of Common Stock to be delivered
to the Investor at the Closing (in accordance with Section 2.02 of this Agreement) shall
correspond with the Advance Notice amount as reduced pursuant to this Section 2.01(e),
except that the Investor may elect to purchase and the Company shall be obligated to sell
up to that number of shares of Common Stock equal to the amount of such reduction divided
by the Minimum Acceptable Price corresponding to such Advance Notice (the “Additional
Shares”) at a price equal to the Minimum Acceptable Price corresponding to such
Advance. For the avoidance of doubt, this exception shall not affect the calculation of
the Purchase Price for the Trading Days in the Pricing Period that are not Excluded Days.

Section 2.02 Closings. The closing of each Advance with respect to each Pricing Period
shall take place on each Advance Settlement Date in accordance with the following procedures:

	 	(a)	 	By 10:30 am on the Trading Day immediately following each Pricing Period the Investor
shall deliver to the Company a written document (each a “Settlement Document”)
setting forth (i) the amount of the Advance (taking into account any adjustments pursuant
to Section 2.01(c) Section 2.01(d), or Section 2.01(e)), (ii) the Net Advance Amount, (iii)
the Minimum Acceptable Price (if any) for the Advance, (iv) the number of Excluded Days (if
any) taken into account in determining the Pricing Period, (v) the Purchase Price, (vi) the
Market Price (as supported by a report by Bloomberg L.P. indicating the VWAP for each of
the Trading Days during the Pricing Period), (vii) the number of Additional Shares, if any,
to be purchased, (viii) the amount payable to the Company, in each case taking into account
the terms and conditions of this Agreement, and (ix) the number of shares of Common Stock
beneficially owned by the Investor as of the date of such Settlement Document. The
Settlement Document shall be substantially in the form attached hereto as Exhibit B and
shall be delivered in accordance with the instructions set forth on the top of Exhibit B or
such other instructions that the Company may provide to the Investor.
	 
	 	(b)	 	Upon receipt of the Settlement Document with respect to each Advance, the Company
shall, by signing the Settlement Document and returning it to the Investor, confirm that it
has obtained all permits and qualifications, if any, required for the issuance and transfer
of the shares of Common Stock applicable to such Advance, or shall have the availability of
exemptions therefrom and that the sale and issuance of such shares of Common Stock shall be
legally permitted by all laws and regulations to which the Company is subject.

6

 

	 	(c)	 	On each Advance Settlement Date the Company will, or will cause its transfer agent to,
electronically transfer such number of shares of Common Stock registered in the name of the
Investor as shall equal (x) the amount of the Advance specified in such Advance Notice (as
may be reduced according to the terms of this Agreement), divided by the Purchase Price and
(y) the Additional Shares, if any, by crediting the Investor’s account or its designee’s
account at the Depository Trust Company through its Deposit Withdrawal Agent Commission
System or by such other means of delivery as may be mutually agreed upon by the parties
hereto (which in all cases shall be freely tradable, registered shares in good deliverable
form) against payment by the Investor of the Net Advance Amount in same day funds to an
account designated by the Company. No fractional shares shall be issued, and any
fractional amounts shall be rounded to the next higher whole number of shares. Any
certificates evidencing shares of Common Stock delivered pursuant hereto shall be free of
restrictive legends.

Section 2.03 Hardship. If the Company defaults in its obligations to deliver the Shares
(which in all cases shall be delivered as registered shares in good deliverable form) on the
Advance Settlement Date, the Company agrees that in addition to and in no way limiting the rights
and obligations set forth in Article V hereto and in addition to any other remedy to which the
Investor is entitled at law or in equity, including, without limitation, specific performance, it
will hold the Investor harmless against any loss, claim, damage, or expense (including reasonable
legal fees and expenses), as incurred, arising out of or in connection with such default by the
Company and acknowledges that irreparable damage would occur in the event of any such default. It
is accordingly agreed that the Investor shall be entitled to an injunction or injunctions to
prevent such breaches of this Agreement and to specifically enforce, without the posting of a bond
or other security, the terms and provisions of this Agreement.

Article III. Representations and Warranties of Investor

     Investor hereby represents and warrants to, and agrees with, the Company that the following
are true and correct as of the date hereof and will remain true and correct throughout the
Commitment Period:

Section 3.01 Organization and Authorization. The Investor is duly incorporated or
organized, validly existing and in good standing under the laws of the Cayman Islands and has all
requisite power and authority to purchase, hold and sell the Shares as provided herein. Each of
the decision to invest and the execution and delivery of this Agreement by such Investor, the
performance by such Investor of its obligations hereunder and the consummation by such Investor of
the transactions contemplated hereby has been duly authorized by all necessary partnership action
by the Investor and requires no other proceedings on the part of the Investor. The undersigned has
the right, power and authority to execute and deliver this Agreement and all other instruments on
behalf of the Investor. This Agreement has been duly executed and delivered by the Investor and,
assuming the execution and delivery hereof and acceptance thereof by the Company, will constitute
the legal, valid and binding obligations of the Investor, enforceable against the Investor in
accordance with its terms.

Section 3.02 Evaluation of Risks. The Investor has such knowledge and experience in
financial, tax and business matters as to be capable of evaluating the merits and risks of, and

7

 

bearing the economic risks entailed by, an investment in the Company and of protecting its
interests in connection with this transaction. It recognizes that its investment in the Company
involves a high degree of risk.

Section 3.03 No Legal or Other Advice from the Company. The Investor acknowledges that it
had the opportunity to review this Agreement and the transactions contemplated by this Agreement
with its own legal counsel and investment and tax advisors. The Investor is relying solely on such
counsel and advisors and not on any statements or representations of the Company or any of the
Company’s representatives or agents for legal, tax or investment advice with respect to this
investment, the transactions contemplated by this Agreement or the securities laws of any
jurisdiction.

Section 3.04 Not an Affiliate. The Investor is not and under no circumstance will the
Investor take any action hereunder or otherwise that would make the Investor or any of its
affiliates or representatives an officer, director or a Person that directly, or indirectly through
one or more intermediaries, controls or is controlled by, or is under common control with the
Company or any “Affiliate” of the Company (as that term is defined in Rule 405 of the
Securities Act).

Section 3.05 Short Position. None of the Investor nor any partner, affiliate, or
subsidiary of the Investor has or will have an open short position in the Common Stock of the
Company during the term of this Agreement.

Section 3.06 Investment Purpose. The securities are being purchased by the Investor for
investment purposes, for its own account only and not on behalf of any other person. The Investor
agrees not to assign or in any way transfer the Investor’s rights to the securities or any interest
therein and acknowledges that the Company will not recognize any purported assignment or transfer
except in accordance with applicable federal and state securities and banking laws. No other
Person has or will have a direct or indirect beneficial interest in the securities. The Investor
agrees not to sell, hypothecate or otherwise transfer the Investor’s securities unless the
securities are registered under federal and applicable state securities laws or unless, in the
opinion of counsel satisfactory to the Company, an exemption from such laws is available. The
Investor intends to immediately resell, in the market, the securities it purchases hereunder,
without any intent or efforts to accumulate such securities. The Investor will not attempt,
individually or together with any other person or group, to directly or indirectly exercise control
of the Company or elect directors of the Company or its bank subsidiaries, or to directly or
indirectly exercise a controlling influence over the management or policies of the Company or any
of its bank subsidiaries. The Investor is not seeking to accumulate securities for its own account
or for the account of any other person.

Section 3.07 Accredited Investor. The Investor is an “Accredited Investor” as that
term is defined in Rule 501(a)(3) of Regulation D under the Securities Act.

Section 3.08 Information. The Investor and its advisors (and its counsel), if any, have
been furnished with all materials relating to the business, finances and operations of the Company
and information it deemed material to making an informed investment decision. The Investor and its
advisors, if any, have been afforded the opportunity to ask questions of the Company and its
management. Neither such inquiries nor any other due diligence investigations conducted by

8

 

such Investor or its advisors, if any, or its representatives shall modify, amend or affect the
Investor’s right to rely on the Company’s representations and warranties contained in this
Agreement. The Investor understands that its investment involves a high degree of risk. The
Investor is in a position regarding the Company, which, based upon employment, family relationship
or economic bargaining power, enabled and enables such Investor to obtain information from the
Company in order to evaluate the merits and risks of this investment. The Investor has sought such
accounting, legal and tax advice, as it has considered necessary to make an informed investment
decision with respect to this transaction.

Section 3.09 Trading Activities. The Investor agrees that it shall not, and that it will
cause its partners, affiliates and subsidiaries not to, engage in any short sales of the Common
Stock, provided that the Company acknowledges and agrees that upon receipt of an Advance
Notice the Investor has the right to sell the shares to be purchased by the Investor pursuant to an
Advance Notice prior to taking possession of such Shares, provided further that
such sale complies with all applicable laws. As of the date of this Agreement, the Investor and
its partners, affiliates, subsidiaries and employees do not beneficially own (as calculated
pursuant to Section 13(d) of the Exchange Act) any shares of Common Stock. During the term of this
Agreement, none of the Investor nor its partners, affiliates, subsidiaries or employees will
purchase or hold any shares of Common Stock other than as contemplated hereby.

Section 3.10 Standstill Agreement. The Investor agrees that during the term of this
Agreement and for a period of one year from the expiration of the Commitment Period, it will not,
provided the Company has delivered to the Investor all Shares relating to any prior Advance and has
not defaulted on any other obligations it has to the Investor and unless (x) specifically consented
to in advance in writing by the Board of Directors of the Company or (y) required in order to
fulfill its obligations to purchase and sell the Shares as set forth in Article II of this
Agreement, directly or indirectly, in any manner:

	 	(a)	 	make, or in any way participate in, directly or indirectly, alone or in concert with
others, any “solicitation” of “proxies” to vote (as such terms are used in the proxy rules
promulgated pursuant to Section 14 of the Exchange Act), whether subject to or exempt from
the proxy rules, or seek to advise or influence in any manner whatsoever any Person with
respect to the voting of any equity securities of the Company, or seek, directly or
indirectly and whether individually or with any other person or group, to influence the
management or policies of the Company;
	 
	 	(b)	 	form, join or in any way participate in a “group” within the meaning of Section
13(d)(3) of the Exchange Act with respect to any voting securities of the Company;
	 
	 	(c)	 	acquire, offer to acquire or agree to acquire, alone or in concert or otherwise with
others, by purchase, exchange or otherwise, (i) any of the assets, tangible and intangible,
of the Company or any of its subsidiaries or (ii) direct or indirect rights, warrants or
options to acquire any assets or securities of the Company or any of its subsidiaries;
	 
	 	(d)	 	otherwise act, alone or in concert or otherwise with others, to seek to propose to the
Company, any of its subsidiaries or any of their respective shareholders any merger,
business combination, restructuring, recapitalization or other transaction involving the

9

 

	 	 	 	Company or any of its subsidiaries or otherwise seek, alone or in concert or otherwise with
others, to control, change or influence the management, the Board of Directors of the
Company or the policies of the Company or any of its subsidiaries or nominate any person as
a director, or propose any matter to be voted upon by the shareholders of the Company or any
of its subsidiaries; or
	 
	 	(e)	 	purchase or hold, or exercise any rights with respect to, any securities of the Company
or any of its subsidiaries, either alone or in concert or otherwise with any other person
or any group; and
	 
	 	(f)	 	publicly announce an intention to do, or enter into any arrangement, understanding or
agreement with others to do, any of the actions restricted or prohibited under this Section
3.10.

Article IV. Representations and Warranties of the Company

     Except as stated below, on the disclosure schedules delivered herewith or in the SEC Documents
(as defined herein), the Registration Statement and the Prospectus (the “SEC Filings”), the
Company hereby represents and warrants to the Investor that the following are true and correct as
of the date hereof:

Section 4.01 Registration Statement and Prospectus.

     (a) The Company meets the requirements for use of Form S-3 under the Securities Act for the
offering of the Shares, including but not limited to the transactions requirements for an offering
made by the issuer set forth in Instruction I.B.6 to Form S-3.

     (b) The Registration Statement, including the Base Prospectus contained therein, was prepared
by the Company in conformity with the requirements of the Securities Act and all applicable U.S.
federal securities laws rules and regulations. Any amendment or supplement to the Registration
Statement or Prospectus required by this Agreement will be so prepared and filed by the Company
and, as applicable, the Company will use its commercially reasonable efforts to cause it to become
effective as soon as reasonably practicable. No stop order suspending the effectiveness of the
Registration Statement has been issued, and no proceeding for that purpose has been instituted or,
to the knowledge of the Company, threatened by the SEC. Any reference herein to the Registration
Statement, the Prospectus, or any amendment or supplement thereto shall be deemed to refer to and
include the documents incorporated (or deemed to be incorporated) by reference therein pursuant to
Item 12 of Form S-3 under the Securities Act, and any reference herein to the terms “amend,”
“amendment” or “supplement” with respect to the Registration Statement or Prospectus shall be
deemed to refer to and include the filing after the execution hereof of any document with the SEC
deemed to be incorporated by reference therein.

     (c) The Company has not distributed and, prior to the completion of the distribution of the
Shares, shall not distribute any offering material in connection with the offering and sale of the
Shares other than the Registration Statement, the Base Prospectus as supplemented by any Prospectus
Supplement or such other materials, if any, permitted by the Securities Act.

10

 

Section 4.02 No Misstatement or Omission. Each part of the Registration Statement, when
such part became or becomes effective, and the Prospectus, on the date of filing thereof with the
SEC and at each date during the Pricing Period and at the Advance Settlement Date conformed or will
conform in all material respects with the requirements of the Securities Act and the rules and
regulations promulgated thereunder; each part of the Registration Statement, when such part became
or becomes effective, did not or will not contain an untrue statement of a material fact or omit to
state a material fact required to be stated therein or necessary to make the statements therein not
misleading; and the Prospectus, on the date of filing thereof with the SEC and at each date during
the Pricing Period and at the Advance Settlement Date did not or will not include an untrue
statement of a material fact or omit to state a material fact necessary to make the statements
therein, in light of the circumstances under which they were made, not misleading; except that the
foregoing shall not apply to statements or omissions in any such document made in reliance on
information furnished in writing to the Company by the Investor expressly stating that such
information is intended for use in the Registration Statement, the Prospectus, or any amendment or
supplement thereto.

Section 4.03 SEC Documents; Financial Statements. The Common Stock is registered pursuant
to Section 12(b) of the Exchange Act and the Company has filed all reports, schedules, forms,
statements and other documents required to be filed by it with the SEC under the Exchange Act (all
of the foregoing filed within the two years preceding the date hereof or amended after the date
hereof and all exhibits included therein and financial statements and schedules thereto and
documents incorporated by reference therein, being hereinafter referred to as the “SEC
Documents”). The Company is current with its filing obligations under the Exchange Act and all
SEC Documents have been filed on a timely basis or the Company has received a valid extension of
such time of filing and has filed any such SEC Document prior to the expiration of any such
extension. As of their respective dates, the SEC Documents complied in all material respects with
the requirements of the Exchange Act and the rules and regulations of the SEC promulgated
thereunder applicable to the SEC Documents, and none of the SEC Documents, at the time they were
filed with the SEC, contained any untrue statement of a material fact or omitted to state a
material fact required to be stated therein or necessary in order to make the statements therein,
in the light of the circumstances under which they were made, not misleading. As of their
respective dates, the financial statements of the Company included in the SEC Documents complied as
to form in all material respects with applicable accounting requirements and the published rules
and regulations of the SEC with respect thereto. Such financial statements have been prepared in
accordance with generally accepted accounting principles, consistently applied, during the periods
involved (except (i) as may be otherwise indicated in such financial statements or the notes
thereto, or (ii) in the case of unaudited interim statements, to the extent they may exclude
footnotes or may be condensed or summary statements) and fairly present the financial position of
the Company as of the dates thereof and the results of its operations and cash flows for the
periods then ended (subject, in the case of unaudited statements, to normal year-end audit
adjustments).

Section 4.04 Organization and Qualification. The Company is duly incorporated, validly
existing and in good standing under the laws of the state of Alabama and has all requisite
corporate power to own its properties and to carry on its business as now being conducted. Each of
the Company and its subsidiaries is duly qualified as a foreign corporation to do business and is
in good standing in every jurisdiction in which the nature of the business conducted by it

11

 

makes such qualification necessary, except to the extent that the failure to be so qualified or be
in good standing would not have a Material Adverse Effect.

Section 4.05 Authorization, Enforcement, Compliance with Other Instruments. (i) The
Company has the requisite corporate power and authority to enter into and perform this Agreement
and any related agreements, in accordance with the terms hereof and thereof, (ii) the execution and
delivery of this Agreement and any related agreements by the Company and the consummation by it of
the transactions contemplated hereby and thereby, have been duly authorized by the Company’s Board
of Directors and no further consent or authorization is required by the Company, its Board of
Directors or its stockholders, (iii) this Agreement and any related agreements have been duly
executed and delivered by the Company, (iv) this Agreement and assuming the execution and delivery
thereof and acceptance by the Investor, any related agreements, constitute the valid and binding
obligations of the Company enforceable against the Company in accordance with their terms, except
as such enforceability may be limited by general principles of equity or applicable bankruptcy,
insolvency, reorganization, moratorium, liquidation or similar laws relating to, or affecting
generally, the enforcement of creditors’ rights and remedies, and except to the extent that rights
to indemnification and contribution may be limited or held unenforceable under applicable federal
or state laws or public policy underlying such laws.

Section 4.06 Capitalization. The authorized capital stock of the Company consists of
100,000,000 shares of Common Stock and 500,000 shares of preferred stock, no par value per share
(“Preferred Stock”), of which 17,684,812 shares of Common Stock and 50,000 shares of
Preferred Stock are issued and outstanding. All of such outstanding shares have been validly
issued and are fully paid and nonassessable. The Common Stock is currently quoted on the Nasdaq
Global Select Market under the trading symbol “BTFG”. No shares of Common Stock are subject to
preemptive rights or any other similar rights or any liens or encumbrances suffered or permitted by
the Company. As of the date hereof, (i) there are no outstanding options, warrants, scrip, rights
to subscribe to, calls or commitments of any character whatsoever relating to, or securities or
rights convertible into, any shares of capital stock of the Company or any of its subsidiaries, or
contracts, commitments, understandings or arrangements by which the Company or any of its
subsidiaries is or may become bound to issue additional shares of capital stock of the Company or
any of its subsidiaries or options, warrants, scrip, rights to subscribe to, calls or commitments
of any character whatsoever relating to, or securities or rights convertible into, any shares of
capital stock of the Company or any of its subsidiaries, (ii) there are no outstanding debt
securities (iii) there are no outstanding registration statements other than the Registration
Statement, registration statements on Form S-8 and the registration statement on Form S-1
(Registration No. 333-128183) filed by the Company with the SEC, and (iv) there are no agreements
or arrangements under which the Company or any of its subsidiaries is obligated to register the
sale of any of their securities under the Securities Act. There are no securities or instruments
containing anti-dilution or similar provisions that will be triggered by this Agreement or any
related agreement or the consummation of the transactions described herein or therein. The Company
has furnished or made available to the Investor true and correct copies of the Company’s Articles
of Incorporation, as amended and as in effect on the date hereof (the “Articles of
Incorporation”), and the Company’s By-laws, as in effect on the date hereof (the
“By-laws”), and the terms of all securities convertible into or exercisable for Common
Stock and the material rights of the holders thereof in respect thereto.

12

 

Section 4.07 No Conflict. The execution, delivery and performance of this Agreement by the
Company and the consummation by the Company of the transactions contemplated hereby will not (i)
result in a violation of the Articles of Incorporation, any certificate of designations of any
outstanding series of Preferred Stock of the Company or By-laws or (ii) conflict with or constitute
a default (or an event which with notice or lapse of time or both would become a default) under, or
give to others any rights of termination, amendment, acceleration or cancellation of, any material
agreement, indenture or instrument to which the Company or any of its subsidiaries is a party, or
result in a violation of any law, rule, regulation, order, judgment or decree (including federal
and state securities laws and regulations and the rules and regulations of the Principal Market on
which the Common Stock is quoted) applicable to the Company or any of its subsidiaries or by which
any material property or asset of the Company or any of its subsidiaries is bound or affected and
which would cause a Material Adverse Effect. Neither the Company nor its subsidiaries is in
violation of any term of or in default under its Articles of Incorporation or By-laws or their
organizational charter or by-laws, respectively, or any material contract, agreement, mortgage,
indebtedness, indenture, instrument, judgment, decree or order or any statute, rule or regulation
applicable to the Company or its subsidiaries that would cause a Material Adverse Effect. The
business of the Company and its subsidiaries is not being conducted in violation of any material
law, ordinance or regulation of any governmental entity. Except as specifically contemplated by
this Agreement, as required under the Securities Act and any applicable state securities laws and
as required by the rules of the Principal Market, the Company is not required to obtain any
consent, authorization or order of, or make any filing or registration with, any court or
governmental agency in order for it to execute, deliver or perform any of its obligations under or
contemplated by this Agreement in accordance with the terms hereof or thereof except as such
consent, authorization or order has been obtained prior to the date hereof. The Company is unaware
of any fact or circumstance which, in its reasonable judgment, might give rise to any of the
foregoing.

Section 4.08 No Default. The Company is not in default in the performance or observance of
any material obligation, agreement, covenant or condition contained in any indenture, mortgage,
deed of trust or other material instrument or agreement to which it is a party or by which it is or
its property is bound and neither the execution, nor the delivery by the Company, nor the
performance by the Company of its obligations under this Agreement or any of the exhibits or
attachments hereto will conflict with or result in the breach or violation of any of the terms or
provisions of, or constitute a default or result in the creation or imposition of any lien or
charge on any assets or properties of the Company under its Articles of Incorporation, By-laws, any
material indenture, mortgage, deed of trust or other material agreement applicable to the Company
or instrument to which the Company is a party or by which it is bound, or any statute, or any
decree, judgment, order, rules or regulation of any court or governmental agency or body having
jurisdiction over the Company or its properties, in each case which default, lien or charge is
likely to cause a Material Adverse Effect.

Section 4.09 Intellectual Property Rights. The Company and its subsidiaries own or possess
adequate rights or licenses to use all material trademarks, trade names, service marks, service
mark registrations, service names, patents, patent rights, copyrights, inventions, licenses,
approvals, governmental authorizations, trade secrets and rights necessary to conduct their
respective businesses as now conducted. The Company and its subsidiaries do not have any
knowledge of any infringement by the Company or its subsidiaries of trademarks, trade name

13

 

rights, patents, patent rights, copyrights, inventions, licenses, service names, service marks,
service mark registrations, trade secrets or other similar rights of others, and, to the knowledge
of the Company, there is no claim, action or proceeding being made or brought against, or to the
Company’s knowledge, being threatened against, the Company or its subsidiaries regarding
trademarks, trade names, patents, patent rights, inventions, copyrights, licenses, service names,
service marks, service mark registrations, trade secrets or other infringement; and the Company is
unaware of any facts or circumstances which, in its reasonable judgment, might give rise to any of
the foregoing.

Section 4.10 Employee Relations. Neither the Company nor any of its subsidiaries is
involved in any labor dispute nor, to the knowledge of the Company, is any such dispute threatened,
in each case as would have a Material Adverse Effect.

Section 4.11 Environmental Laws. Except as would not have a Material Adverse Effect, the
Company and its subsidiaries are (i) in compliance with any and all applicable material foreign,
federal, state and local laws and regulations relating to the protection of human health and
safety, the environment or hazardous or toxic substances or wastes, pollutants or contaminants
(“Environmental Laws”), (ii) have received all permits, licenses or other approvals
required of them under applicable Environmental Laws to conduct their respective businesses and
(iii) are in compliance with all terms and conditions of any such permit, license or approval.

Section 4.12 Title. The Company has good and marketable title to its properties and
material assets owned by it, free and clear of any pledge, lien, security interest, encumbrance,
claim or equitable interest other than such as are not material to the business of the Company.
Any real property and facilities held under lease by the Company and its subsidiaries are held by
them under valid, subsisting and enforceable leases with such exceptions as are not material and do
not interfere with the use made and proposed to be made of such property and buildings by the
Company and its subsidiaries.

Section 4.13 Insurance. The Company and each of its subsidiaries are insured against such
losses and risks and in such amounts as management of the Company believes to be prudent and
customary for similarly situated companies in the businesses in which the Company and its
subsidiaries are engaged. Neither the Company nor any such subsidiary has any reason to believe
that it will not be able to renew its existing insurance coverage as and when such coverage expires
or to obtain similar coverage from similar insurers as may be necessary to continue its business at
a cost that would not have a Material Adverse Effect.

Section 4.14 Regulatory Permits. The Company and its subsidiaries possess all material
certificates, authorizations and permits issued by the appropriate federal, state or foreign
regulatory authorities necessary to conduct their respective businesses, and neither the Company
nor any such subsidiary has received any notice of proceedings relating to the revocation or
modification of any such certificate, authorization or permit.

Section 4.15 Internal Accounting Controls. The Company and each of its subsidiaries
maintain a system of internal accounting controls sufficient to provide reasonable assurance that
(i) transactions are executed in accordance with management’s general or specific authorizations,
(ii) transactions are recorded as necessary to permit preparation of financial statements in

14

 

conformity with generally accepted accounting principles and to maintain asset accountability,
(iii) access to assets is permitted only in accordance with management’s general or specific
authorization and (iv) the recorded accountability for assets is compared with the existing assets
at reasonable intervals and appropriate action is taken with respect to any differences.

Section 4.16 No Material Adverse Breaches, etc. Neither the Company nor any of its
subsidiaries is subject to any charter, corporate or other legal restriction, or any judgment,
decree, order, rule or regulation which in the judgment of the Company’s officers has or is
expected in the future to have a Material Adverse Effect. Neither the Company nor any of its
subsidiaries is in breach of any contract or agreement which breach, in the judgment of the
Company’s officers, has or is expected to have, individually or in the aggregate, a Material
Adverse Effect.

Section 4.17 Absence of Litigation. Other than periodic examinations and inquiries of the
Company and its banking subsidiary by federal and state banking regulators, there is no action,
suit, proceeding, inquiry or investigation before or by any court, public board, government agency,
self-regulatory organization or body pending against or affecting the Company, the Common Stock or
any of the Company’s subsidiaries, wherein an unfavorable decision, ruling or finding would have a
Material Adverse Effect.

Section 4.18 Tax Status. Subject to valid extensions, the Company and each of its
subsidiaries has made or filed all material federal and state income and all other tax returns,
reports and declarations required by any jurisdiction to which it is subject and (unless and only
to the extent that the Company and each of its subsidiaries has set aside on its books provisions
reasonably adequate for the payment of all unpaid and unreported taxes) has paid all taxes and
other governmental assessments and charges that are material in amount, shown or determined to be
due on such returns, reports and declarations, except those being contested in good faith and has
set aside on its books provision reasonably adequate for the payment of all taxes for periods
subsequent to the periods to which such returns, reports or declarations apply. There are no
unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction,
and the officers of the Company know of no basis for any such claim.

Section 4.19 Certain Transactions. None of the officers or directors of the Company is
currently a party to any transaction with the Company (other than for services as officers and
directors), including any contract, agreement or other arrangement providing for the furnishing of
services to or by, providing for rental of real or personal property to or from, or otherwise
requiring payments to or from any officer or director or, to the knowledge of the Company, any
corporation, partnership, trust or other entity in which any officer or director has a substantial
interest or is an officer, director, trustee or partner that are required to be described in the
SEC Filings that are not so described.

Section 4.20 The Shares. The Shares have been duly authorized and, when issued, delivered
and paid for pursuant to this Agreement, will be validly issued and fully paid and non-assessable,
free and clear of all encumbrances and will be issued in compliance with all applicable United
States federal and state securities laws; the capital stock of the Company, including the Common
Stock, conforms in all material respects to the description thereof contained in the Registration
Statement and the Common Stock, including the Shares, will conform to the description thereof

15

 

contained in the Prospectus as amended or supplemented. Neither the stockholders of the Company,
nor any other Person have any preemptive rights or rights of first refusal with respect to the
Shares or other rights to purchase or receive any of the Shares or any other securities or assets
of the Company, and no Person has the right, contractual or otherwise, to cause the Company to
issue to it, or register pursuant to the Securities Act, any shares of capital stock or other
securities or assets of the Company upon the issuance or sale of the Shares. The Company is not
obligated to offer the Shares on a right of first refusal basis or otherwise to any third parties
including, but not limited to, current or former shareholders of the Company, underwriters, brokers
or agents.

Section 4.21 Dilution. The Company is aware and acknowledges that issuance of shares of the
Common Stock could cause dilution to existing shareholders and could significantly increase the
outstanding number of shares of Common Stock.

Section 4.22 Acknowledgment Regarding Investor’s Purchase of Shares. The Company
acknowledges and agrees that the Investor is acting solely in the capacity of an arm’s length
investor with respect to this Agreement and the transactions contemplated hereunder. The Company
further acknowledges that the Investor is not acting as a financial advisor or fiduciary of the
Company (or in any similar capacity) with respect to this Agreement and the transactions
contemplated hereunder and any advice given by the Investor or any of its representatives or agents
in connection with this Agreement and the transactions contemplated hereunder is merely incidental
to the Investor’s purchase of the Shares hereunder. The Company is aware and acknowledges that it
may not be able to request Advances under this Agreement if the Registration Statement ceases to be
effective or if any issuances of Common Stock pursuant to any Advances would violate any rules of
the Principal Market.

Article V. Indemnification

     The Investor and the Company covenant to the other the following with respect to itself:

Section 5.01 Indemnification by the Company. The Company agrees to indemnify and hold
harmless the Investor and the Investor’s affiliates, directors, officers, employees and agents and
each Person who controls the Investor within the meaning of Section 15 of the Act or Section 20 of
the Exchange Act against any and all losses, claims, damages, expenses or liabilities, joint or
several, to which they or any of them may become subject under the Securities Act, the Exchange Act
or other federal or state statutory law or regulation, at common law or otherwise, insofar as such
losses, claims, damages, expenses or liabilities (or actions in respect thereof) arise out of or
are based upon any untrue statement or alleged untrue statement of a material fact contained in the
Registration Statement for the registration of the Shares as originally filed or in any amendment
thereof, or in the Prospectus, or in any Prospectus Supplement, or in any amendment thereof or
supplement thereto, or arise out of or are based upon the omission or alleged omission to state
therein a material fact required to be stated therein or necessary to make the statements therein
not misleading, and agrees to reimburse each such indemnified party, as incurred, for any legal or
other expenses reasonably incurred by them in connection with investigating, defending or settling
any such loss, claim, damage, liability, expense or action; provided, however, that
the Company will not be liable in any such case to the extent that any such loss, claim, damage or
liability arises out of or is based upon any such untrue statement or

16

 

alleged untrue statement or omission or alleged omission made therein in reliance upon and in
conformity with written information furnished to the Company by or on behalf of the Investor
specifically for inclusion therein.

Section 5.02 Indemnification by the Investor. The Investor agrees to indemnify and hold
harmless the Company, each of its directors, each of its officers who signs the Registration
Statement, and each Person who controls the Company within the meaning of Section 15 of the Act or
Section 20 of the Exchange Act to the same extent as the foregoing indemnity to the Investor, but
only with reference to written information relating to such Investor furnished to the Company by or
on behalf of the Investor specifically for inclusion in the documents referred to in the foregoing
indemnity.

Section 5.03 Notice of Claim. Promptly after receipt by an indemnified party under this
Article V of notice of the commencement of any action, such indemnified party will, if a claim in
respect thereof is to be made against the indemnifying party under this Article V, notify the
indemnifying party in writing of the commencement thereof; but the failure so to notify the
indemnifying party (i) will not relieve it from liability under Section 5.01 or Section 5.02 above
unless and to the extent the indemnifying party did not otherwise learn of such action and such
failure results in the forfeiture by the indemnifying party of substantial rights and defenses and
(ii) will not, in any event, relieve the indemnifying party from any obligations to any indemnified
party other than the indemnification obligation provided in Section 5.01 or Section 5.02 above. In
the case of parties indemnified pursuant to Section 5.01 above, counsel to the indemnified parties
shall be selected by the Company, and, in the case of parties indemnified pursuant to Section 5.02
above, counsel to the indemnified parties shall be selected by the Investor. An indemnifying party
may participate at its own expense in the defense of any such action; provided,
however, that counsel to the indemnifying party shall not (except with the consent of the
indemnified party) also be counsel to the indemnified party. In no event shall the indemnifying
parties be liable for fees and expenses of more than one counsel (in addition to any local counsel)
separate from their own counsel for all indemnified parties in connection with any one action or
separate but similar or related actions in the same jurisdiction arising out of the same general
allegations or circumstances. An indemnifying party will not, without the prior written consent of
the indemnified parties, settle or compromise or consent to the entry of any judgment with respect
to any pending or threatened claim, action, suit or proceeding in respect of which indemnification
or contribution may be sought under this Agreement (whether or not the indemnified parties are
actual or potential parties to such claim or action) unless (i) such settlement, compromise or
consent includes an unconditional release of each indemnified party from all liability arising out
of such claim, action, suit or proceeding and (ii) such settlement, compromise or consent does not
include a statement as to or an admission of fault, culpability or a failure to act by or on behalf
of any indemnified party.

Section 5.04 Contribution. In the event that the indemnity provided in Section 5.01 or
Section 5.02 is unavailable to or insufficient to hold harmless an indemnified party for any
reason, the Company and the Investor severally agree to contribute to the aggregate losses, claims,
damages and liabilities (including legal or other expenses reasonably incurred in connection with
investigating or defending the same) (collectively “Losses”) to which the Company and the
Investor may be subject in such proportion as is appropriate to reflect the relative benefits
received by the Company on the one hand and by the Investor on the other from transactions

17

 

contemplated by this Agreement. If the allocation provided by the immediately preceding sentence is
unavailable for any reason, the Company and the Investor severally shall contribute in such
proportion as is appropriate to reflect not only such relative benefits but also the relative fault
of the Company on the one hand and of the Investor on the other in connection with the statements
or omissions which resulted in such Losses as well as any other relevant equitable considerations.
Benefits received by the Company shall be deemed to be equal to the total proceeds from the
offering (net of underwriting discounts and commissions but before deducting expenses) received by
it, and benefits received by the Investor shall be deemed to be equal to the total discounts
received by the Investor. Relative fault shall be determined by reference to, among other things,
whether any untrue or any alleged untrue statement of a material fact or the omission or alleged
omission to state a material fact relates to information provided by the Company on the one hand or
the Investor on the other, the intent of the parties and their relative knowledge, access to
information and opportunity to correct or prevent such untrue statement or omission. The Company
and the Investor agree that it would not be just and equitable if contribution were determined by
pro rata allocation or any other method of allocation which does not take account of the equitable
considerations referred to above. The aggregate amount of losses, liabilities, claims, damages and
expenses incurred by an indemnified party and referred to above in this Article V shall be deemed
to include any legal or other expenses reasonably incurred by such indemnified party in
investigating, preparing or defending against any litigation, or any investigation or proceeding by
any governmental agency or body, commenced or threatened, or any claim whatsoever based upon any
such untrue or alleged untrue statement or omission or alleged omission. Notwithstanding the
provisions of this Section 5.04, the Investor shall not be required to contribute any amount in
excess of the amount by which the Purchase Price for Shares actually purchased pursuant to this
Agreement exceeds the amount of any damages which the Investor has otherwise been required to pay
by reason of such untrue or alleged untrue statement or omission or alleged omission. No Person
guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act)
shall be entitled to contribution from any Person who was not guilty of such fraudulent
misrepresentation. For purposes of this Article V, each Person who controls the Investor within the
meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act and each director,
officer, employee and agent of the Investor shall have the same rights to contribution as the
Investor, and each Person who controls the Company within the meaning of Section 15 of the
Securities Act or Section 20 of the Exchange Act, each officer of the Company who shall have signed
the Registration Statement and each director of the Company shall have the same rights to
contribution as the Company, subject in each case to the applicable terms and conditions of this
Section 5.04.

Section 5.05 Remedies. The remedies provided for in this Article V are not exclusive and
shall not limit any rights or remedies which may otherwise be available to any indemnified party at
law or in equity. The obligations of the parties to indemnify or make contribution under this
Article V shall survive termination.

Article VI.

Covenants of the Company

Section 6.01 Effective Registration Statement. During the Commitment Period, the Company
shall notify the Investor promptly if (i) the Registration Statement shall cease to be effective

18

 

under the Securities Act, (ii) the Common Stock shall cease to be authorized for listing on the
Principal Market, (iii) the Common Stock ceases to be registered under Section 12(b) or Section
12(g) of the Exchange Act or (iv) the Company fails to file in a timely manner all reports and
other documents required of it as a reporting company under the Exchange Act. If the third
anniversary (the “Renewal Deadline”) of the initial effective date of the Registration
Statement falls during the Commitment Period, the Company will, prior to the Renewal Deadline file,
if it has not already done so and is eligible to do so, a new automatic shelf registration
statement relating to the Shares, in a form satisfactory to the Investor. If the Company is not
eligible to file an automatic shelf registration statement, the Company will, prior to the Renewal
Deadline, if it has not already done so, file a new shelf registration statement relating to the
Shares, in a form reasonably satisfactory to the Investor, and will use its commercially reasonable
efforts to cause such registration statement to be declared effective within 60 days after the
Renewal Deadline. The Company will take all other action necessary or appropriate to permit the
issuance and sale of the Shares to continue as contemplated in the expired registration statement
relating to the Shares. References in this Agreement to the Registration Statement shall include
such new automatic shelf registration statement or such new shelf registration statement, as the
case may be.

Section 6.02 Corporate Existence. The Company will take all steps necessary to preserve
and continue the corporate existence of the Company.

Section 6.03 Notice of Certain Events Affecting Registration; Suspension of Right to Make an
Advance. The Company will promptly notify the Investor, and confirm in writing, upon its
becoming aware of the occurrence of any of the following events: (i) receipt of any request for
additional information by the SEC or any other federal or state governmental authority for
amendments or supplements to the Registration Statement, the Prospectus or for any additional
information relating to the Registration Statement or Prospectus; (ii) the issuance by the SEC or
any other federal or state governmental authority of any stop order suspending the effectiveness
of the Registration Statement or the initiation of any proceedings for that purpose; (iii) receipt
of any notification with respect to the suspension of the qualification or exemption from
qualification of any of the Common Stock for sale in any jurisdiction or the initiation or
threatening of any proceeding for such purpose; (iv) the happening of any event that makes any
statement made in the Registration Statement or Prospectus or any document incorporated or deemed
to be incorporated therein by reference untrue in any material respect or that requires the making
of any changes in the Registration Statement, Prospectus or documents so that, in the case of the
Registration Statement, it will not contain any untrue statement of a material fact or omit to
state any material fact required to be stated therein or necessary to make the statements therein
not misleading, and that in the case of the Prospectus, it will not contain any untrue statement of
a material fact or omit to state any material fact required to be stated therein or necessary to
make the statements therein, in the light of the circumstances under which they were made, not
misleading, or of the necessity to amend the Registration Statement or supplement the Prospectus to
comply with the Securities Act or any other law; and (v) the Company’s reasonable determination
that a post-effective amendment to the Registration Statement would be appropriate; and the Company
will promptly make available to the Investor any such supplement or amendment to the related
prospectus. The Company shall not deliver to the Investor any Advance Notice during the
continuation of any of the foregoing events.

19

 

Section 6.04 Prospectus Delivery. The Company agrees that on such dates as the
Securities Act shall require, the Company will file a Prospectus Supplement or other appropriate
form as determined by counsel with the SEC under the applicable paragraph of Rule 424(b) under the
Securities Act, which Prospectus Supplement will set forth, within the relevant period, the amount
of Shares sold to the Investor, the net proceeds to the Company and the discount paid by the
Investor with respect to such Shares. The Company shall provide the Investor at least 24 hours to
comment on a draft of each such Prospectus Supplement (and shall give due consideration to all such
comments) and shall deliver or make available to the Investor, without charge, an electronic copy
of each form of Prospectus Supplement, together with the Base Prospectus. The Company consents to
the use of the Prospectus (and of any Prospectus Supplement thereto) in accordance with the
provisions of the Securities Act and with the securities or “blue sky” laws of the jurisdictions in
which the Shares may be sold by the Investor, in connection with the offering and sale of the
Shares and for such period of time thereafter as the Prospectus is required by the Securities Act
to be delivered in connection with sales of the Shares. If during such period of time any event
shall occur that in the judgment of the Company and its counsel is required to be set forth in the
Prospectus or should be set forth therein in order to make the statements made therein, in the
light of the circumstances under which they were made, not misleading, or if it is necessary to
supplement or amend the Prospectus to comply with the Securities Act or any other applicable law or
regulation, the Company shall forthwith prepare and file with the SEC an appropriate Prospectus
Supplement to the Prospectus and shall promptly furnish or make available to the Investor an
electronic copy thereof.

Section 6.05 Listing of Shares. The Company will use commercially reasonable efforts to
cause the Shares to be listed on the Principal Market and to qualify the Shares for sale under the
securities laws of such jurisdictions as are required by law in the reasonable opinion of
Investor’s counsel and that the Investor designates; provided that the Company shall not be
required in connection therewith to qualify as a foreign corporation or to file a general consent
to service of process in any jurisdiction.

Section 6.06 Consolidation; Merger. If an Advance Notice has been delivered to the Investor
and the transaction contemplated in such Advance Notice has not yet been closed in accordance with
Section 2.02 hereof, then the Company shall not affect any merger or consolidation of the Company
with or into, or a transfer of all or substantially all the assets of the Company to another entity
(a “Consolidation Event”).

Section 6.07 Issuance of the Company’s Common Stock. The sale of Shares hereunder shall be
made in accordance with the provisions and requirements of the Securities Act and any applicable
state securities law.

Section 6.08 Use of Proceeds. The Company shall use the net proceeds from this offering as
disclosed in the Prospectus.

Section 6.09 Expenses. The Company, whether or not the transactions contemplated hereunder
are consummated or this Agreement is terminated, will pay all expenses incident to the performance
of its obligations hereunder, including but not limited to (i) the preparation, printing and filing
of the Registration Statement and each amendment and supplement thereto, of each Prospectus and of
each amendment and supplement thereto; (ii) the preparation, issuance and

20

 

delivery of any Shares issued pursuant to this Agreement, (iii) all fees and disbursements of the
Company’s counsel, accountants and other advisors, (iv) the qualification of the Shares under
securities laws in accordance with the provisions of this Agreement, including filing fees in
connection therewith, (v) the printing and delivery of copies of the Prospectus and any amendments
or supplements thereto, (vi) the fees and expenses incurred in connection with the listing or
qualification of the Shares for trading on the Principal Market, or (vii) filing fees of the SEC
and the Financial Industry Regulatory Authority, Inc. Corporate Finance Department.

Section 6.10 Compliance with Laws. The Company will not, directly or indirectly, take any
action designed to cause or result in, or that constitutes or might reasonably be expected to
constitute, the stabilization or manipulation of the price of any security of the Company or which
caused or resulted in, or which would in the future reasonably be expected to cause or result in,
stabilization or manipulation of the price of any security of the Company.

Section 6.11 Comfort Letters. Provided that the Investor is then a person who would be
entitled to a statutory due diligence defense under Section 11 of the Securities Act, at the
request of the Investor and within a reasonable period of time after (i) the date hereof, (ii) the
date the Registration Statement or the Prospectus shall be amended (other than (1) in connection
with the filing of a prospectus supplement that contains solely the information required pursuant
to Section 6.04 hereof, (2) in connection with the filing of any report or other document under
Section 13, 14 or 15(d) of the Exchange Act or (3) by a prospectus supplement relating to the
offering of other securities (including, without limitation, other shares of Common Stock)) (each
such date, a “Registration Statement Amendment Date”) and (iii) the date of filing or
amending each Annual Report on Form 10-K and Quarterly Report on Form 10-Q for a period in which an
Advance was delivered pursuant to this Agreement and which are incorporated by reference in the
Registration Statement (each such date, a “Company Periodic Report Date”), the Company will
request that its independent accountants furnish to the Investor a letter, dated the date hereof,
the Registration Statement Amendment Date or the Company Periodic Report Date, as the case may be,
in form and substance reasonably satisfactory to the Investor, containing statements and
information of the type ordinarily included in accountants’ “comfort letters” to underwriters with
respect to the financial statements of the Company.

Section 6.12 Opinion of Counsel. Prior to the date of the first Advance Notice, the
Investor shall have received an opinion letter from counsel to the Company in the form attached
hereto as Exhibit C.

Section 6.13 Current Report. Promptly after the date hereof (and prior to the Company
delivering an Advance Notice to the Investor hereunder), the Company shall file with the SEC a
report on Form 8-K or such other appropriate form as determined by counsel to the Company, relating
to the transactions contemplated by this Agreement and a preliminary Prospectus Supplement pursuant
to Rule 424(b) of the Securities Act disclosing all information relating to the transaction
contemplated hereby required to be disclosed therein (collectively, the “Initial
Disclosure”) and shall provide the Investor with 24 hours to review the Initial Disclosure
prior to its filing.

Section 6.14 Sales. Without the written consent of the Investor, the Company will not,
directly or indirectly, offer to sell, sell, contract to sell, grant any option to sell or
otherwise dispose of

21

 

any shares of Common Stock (other than the Shares offered pursuant to the provisions of this
Agreement) or securities convertible into or exchangeable for Common Stock, warrants or any rights
to purchase or acquire, Common Stock during the period beginning on the 5th Trading Day immediately
prior to an Advance Notice Date and ending on the 2nd Trading Day immediately following the
corresponding Advance Settlement Date.

Section 6.15 Insider Trading. Notwithstanding any other provision of this Agreement, the
Company shall not deliver an Advance Notice during any period in which the Company is in possession
of material non-public information.

Article VII.

Conditions for Advance and Conditions to Closing

     The right of the Company to deliver an Advance Notice and the obligations of the Investor
hereunder with respect to an Advance is subject to the satisfaction by the Company, on each
Advance Notice Date and Advance Settlement Date (a “Condition Satisfaction Date”), of each
of the following conditions:

Section 7.01 Accuracy of the Company’s Representations and Warranties. The representations
and warranties of the Company shall be true and correct in all material respects.

Section 7.02 Registration of the Common Stock with the SEC. The Registration Statement
shall be effective and the Company shall not be aware of any of the events set forth in Section
6.03 hereof. The Initial Disclosure shall have been filed with the SEC, all Prospectus Supplements
shall have been filed with the SEC, as required pursuant to Section 6.04 in connection with all
prior Advances and an electronic copy of such Prospectus Supplement together with the Base
Prospectus shall have been delivered or made available to the Investor. The Company shall have
filed with the SEC in a timely manner all reports, notices and other documents required of a
“reporting company” under the Exchange Act and applicable SEC regulations.

Section 7.03 Authority. The Company shall have obtained all permits and qualifications
required by any applicable state for the offer and sale of the shares of Common Stock, or shall
have the availability of exemptions therefrom. The sale and issuance of the shares of Common Stock
shall be legally permitted by all laws and regulations to which the Company is subject.

Section 7.04 No Material Notices. None of the following events shall have occurred and be
continuing: (i) any request for additional information from the SEC or any other federal or state
governmental, administrative or self regulatory authority during the period of effectiveness of the
Registration Statement, the response to which would require any amendments or supplements to the
Registration Statement or Prospectus, has not been adequately addressed by the Company; (ii) any
stop order suspending the effectiveness of the Registration Statement or the initiation of any
proceedings for that purpose has been issued by the SEC or any other federal or state governmental
authority; (iii) the suspension of the qualification or exemption from qualification of any of the
Shares for sale in any jurisdiction or the initiation or threatening of any proceeding for such
purpose; and (iv) any event has occurred that makes any statement made in the Registration
Statement or the Prospectus or any document incorporated or deemed to be

22

 

incorporated therein by reference, considered together, untrue in any material respect or that
requires the making of any changes in the Registration Statement, Prospectus or documents so that,
in the case of the Registration Statement, it will not contain any untrue statement of a material
fact or omit to state any material fact required to be stated therein or necessary to make the
statements therein not misleading, and that in the case of the Prospectus, it will not contain any
untrue statement of a material fact or omit to state any material fact required to be stated
therein or necessary to make the statements therein, in the light of the circumstances under which
they were made, not misleading.

Section 7.05 Performance by the Company. The Company shall have performed, satisfied and
complied in all material respects with all covenants, agreements and conditions required by this
Agreement to be performed, satisfied or complied with by the Company at or prior to each Condition
Satisfaction Date.

Section 7.06 No Injunction. No statute, rule, regulation, executive order, decree, ruling
or injunction shall have been enacted, entered, promulgated or endorsed by any court or
governmental authority of competent jurisdiction that prohibits or directly and adversely affects
any of the transactions contemplated by this Agreement, and no proceeding shall have been commenced
that may have a Material Adverse Effect.

Section 7.07 No Suspension of Trading in or Delisting of Common Stock. The Common Stock
shall be trading on the Principal Market and all of the Shares issuable pursuant to such Advance
Notice shall have been approved for listing on the Principal Market and the Company believes, in
good faith, that trading of the Common Stock on the Principal Market will continue uninterrupted
for the foreseeable future. The issuance of Shares with respect to the applicable Advance Notice
will not violate the shareholder approval requirements, if any, of the Principal Market. The
Company shall not have received any notice threatening the continued listing of the Common Stock on
the Principal Market (unless the concerns of the Principal Market have been addressed and the
Investor is reasonably satisfied that the Principal Market is no longer considering or no longer
intends to take such action).

Section 7.08 Authorized. There shall be a sufficient number of authorized but unissued and
otherwise unreserved shares of Common Stock for the issuance of all of the Shares issuable pursuant
to such Advance Notice.

Section 7.09 Consecutive Advance Notices. Except with respect to the first Advance Notice,
the Company shall have delivered all Shares relating to all prior Advances.

Section 7.10 Executed Advance Notice. The Investor shall have received the Advance Notice
in compliance with the Advance parameters set forth in Section 2.01 executed by an officer of the
Company and the representations contained in such Advance Notice shall be true and correct as of
the Condition Satisfaction Date relating to such Advance Notice.

Article VIII.

Non-Disclosure of Non-Public Information

     Nothing herein shall require the Company to disclose non-public information to the Investor or
its advisors or representatives, provided, however, that notwithstanding anything

23

 

herein to the contrary, during any period from and including the delivery of an Advance Notice
through and including the occurrence of the related Advance Settlement Date, the Company will
promptly notify the Investor or its advisors or representatives of any event or the existence of
any circumstance (without any obligation to disclose the specific event or circumstance) of which
it becomes aware, constituting non-public information (whether or not requested of the Company
specifically or generally during the course of due diligence by such Persons), which, if not
disclosed in the Prospectus would cause such Prospectus to include a material misstatement or to
omit a material fact required to be stated therein in order to make the statements, therein, in
light of the circumstances in which they were made, not misleading.

          The Investor agrees that, upon becoming aware of any material, non-public information
regarding the Company that is not set forth in any SEC Filing, it will cease trading in any
securities of the Company until such information is disclosed to the public.

          The Company shall hold in confidence and not make any disclosure of information concerning the
Investor provided to the Company unless (i) disclosure of such information is necessary to comply
with federal or state securities laws, (ii) the disclosure of such information is necessary to
avoid or correct a misstatement or omission in any Registration Statement or Prospectus, (iii) the
release of such information is ordered pursuant to a subpoena or other final, non-appealable order
from a court or governmental body of competent jurisdiction, or (iv) such information has been made
generally available to the public other than by disclosure in violation of this Agreement. The
Company agrees that it shall, upon learning that disclosure of such information concerning the
Investor is sought in or by a court or governmental body of competent jurisdiction or through other
means, give prompt written notice to the Investor and allow the Investor, at the Investor’s
expense, to undertake appropriate action to prevent disclosure of, or to obtain a protective order
for, such information.

Article IX.

Choice of Law/Jurisdiction

          This Agreement shall be governed by and interpreted in accordance with the laws of the State
of New York without regard to the principles of conflict of laws.

Article X. Assignment; Termination

Section 10.01 Assignment. Neither this Agreement nor any rights or obligations of either
party hereunder may be assigned to any other Person without the prior written consent of all
parties hereto.

Section 10.02 Termination.

	 	(a)	 	Unless earlier terminated as provided hereunder, this Agreement shall terminate
automatically on the earliest of (i) the date that is 24 months from the Effective Date, or
(ii) the date on which the Investor shall have made payment of Advances pursuant to this
Agreement in the aggregate amount of the Commitment Amount.
	 
	 	(b)	 	The Company may terminate this Agreement at any time upon prior written notice to the
Investor; provided that upon such termination (i) there are no Advances
outstanding, and

24

 

	 		 	(ii) the Company has paid all amounts owed to the Investor pursuant to this Agreement. This
Agreement may be terminated at any time by the mutual written consent of the parties,
effective as of the date of such mutual written consent unless otherwise provided in such
written consent. In the event of any termination of this Agreement by the Company
hereunder, so long as the Investor owns any shares of Common Stock issued hereunder, the
Company shall not for 20 Trading Days from the date of such termination, voluntarily delist
the Common Stock from the Principal Market.
	 
	 	(c)	 	The obligation of the Investor to make an Advance to the Company pursuant to this
Agreement shall terminate permanently (including with respect to an Advance Settlement Date
that has not yet occurred) in the event that (i) there shall occur any stop order or
suspension of the effectiveness of the Registration Statement for an aggregate of 50
Trading Days, other than due to the acts of the Investor, during the Commitment Period, or
(ii) the Company shall at any time fail materially to comply with the requirements of
Article VI and such failure is not cured within 30 days after receipt of written notice
from the Investor, provided, however, that this termination provision shall
not apply to any period commencing upon the filing of a post-effective amendment to such
Registration Statement and ending upon the date on which such post effective amendment is
declared effective by the SEC, provided further, however, that this
termination provision shall not apply to any period commencing upon the filing of a
successor shelf registration statement to such Registration Statement and ending upon the
date on which such successor shelf registration statement is declared effective by the SEC.
	 
	 	(d)	 	Nothing in this Section 10.02 shall be deemed to release the Company or the Investor
from any liability for any breach under this Agreement, or to impair the rights of the
Company and the Investor to compel specific performance by the other party of its
obligations under this Agreement. The indemnification provisions contained in Article V
shall survive termination hereunder.

Article XI. Notices

          Any notices, consents, waivers, or other communications required or permitted to be given
under the terms of this Agreement must be in writing and will be deemed to have been delivered (i)
upon receipt, when delivered personally; (ii) upon receipt, when sent by facsimile, provided a copy
is mailed by U.S. certified mail, return receipt requested; (iii) 3 days after being sent by U.S.
certified mail, return receipt requested, or (iv) 1 day after deposit with a nationally recognized
overnight delivery service, in each case properly addressed to the party to receive the same. The
addresses and facsimile numbers for such communications, except for Advance Notices which shall be
delivered in accordance with Section 2.01(b) hereof and Settlement Documents which shall be
delivered in accordance with Section 2.02(a) hereof, shall be:

25

 

	 	 	 

	If to the Company, to:

	 	BancTrust Financial Group, Inc.
	 

	 	100 St. Joseph Street 
	 

	 	Mobile, Alabama 36602
	 

	 	Attention: Mike Johnson
	 

	 	Telephone: (251) 431-7813
	 

	 	Facsimile: (251) 431-7851
	 
	 	 
	With a copy to:

	 	Hand Arendall LLC
	 

	 	11 North Water Street 
	 

	 	Suite 30200
	 

	 	Mobile, Alabama 36602
	 

	 	Attention: Brooks P. Milling
	 

	 	Telephone: (251) 694-6275
	 

	 	Facsimile: (251) 694-6375
	 
	 	 
	If to the Investor(s):

	 	YA Global Master SPV Ltd.
	 

	 	101 Hudson Street — Suite 3700 
	 

	 	Jersey City, NJ 07302
	 

	 	Attention: Mark Angelo
	 

	 	Portfolio
Manager

	 

	 	Telephone: (201) 985-8300
	 

	 	Facsimile: (201) 985-8266
	 
	 	 
	With a Copy to:

	 	David Gonzalez, Esq.
	 

	 	Yorkville Advisors, LLC
	 

	 	101 Hudson Street — Suite 3700
	 

	 	Jersey City, NJ 07302
	 

	 	Telephone: (201) 985-8300
	 

	 	Facsimile: (201) 985-8266

Each party shall provide 5 days’ prior written notice to the other party of any change in address
or facsimile number.

Article XII. Miscellaneous

Section 12.01 Counterparts. This Agreement may be executed in two or more identical
counterparts, all of which shall be considered one and the same agreement and shall become
effective when counterparts have been signed by each party and delivered to the other party.

Section 12.02 Reporting Entity for the Common Stock. The reporting entity relied upon for
the determination of the trading price or trading volume of the Common Stock on any given Trading
Day for the purposes of this Agreement shall be Bloomberg, L.P. or any successor thereto. The
written mutual consent of the Investor and the Company shall be required to employ any other
reporting entity.

26

 

Section 12.03 Brokerage. Other than the Placement Agent, each of the parties hereto
represents that it has had no dealings in connection with this transaction with any finder or
broker who will demand payment of any fee or commission from the other party. The Company on the
one hand, and the Investor, on the other hand, agree to indemnify the other against and hold the
other harmless from any and all liabilities to any Person claiming brokerage commissions or
finder’s fees on account of services purported to have been rendered on behalf of the indemnifying
party in connection with this Agreement or the transactions contemplated hereby.

Section 12.04 Amendment. This Agreement may be modified or amended only by a writing
executed by all parties hereto. The parties will cooperate and use their commercially reasonable
best efforts to amend this Agreement, and to otherwise provide assurances, to respond to any
requests of the Company’s regulators.

Section 12.05 Regulatory Matters. The Investor confirms that the it does not have and will
not exercise, directly or indirectly, with or in concert with any other person or group, “control”
over the Company for purposes of the BHC Act and the CIBC Act.

Section 12.06 Fees and Expenses. Each of the parties shall pay its own fees and expenses
(including the fees of any attorneys, accountants, appraisers or others engaged by such party) in
connection with this Agreement and the transactions contemplated hereby, except that the Company
shall pay a structuring fee of $50,000 to Yorkville Advisors, LLC, of which $10,000 has been paid
and the remaining $40,000 shall be paid on the date hereof. In addition, on the first Advance
Settlement Date, the Company shall pay a fee of $100,000 to the Company Financial Advisor.

Section 12.07 Integration. This Agreement, along with any exhibits or amendments hereto,
encompasses the entire agreement of the parties with respect to the subject matter hereof and
supersedes all previous understandings and agreements between the parties, whether oral or written,
with respect to the subject matter hereof.

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

27

 

     IN WITNESS WHEREOF, the parties hereto have caused this Standby Equity Distribution Agreement
to be executed by the undersigned, thereunto duly authorized, as of the date first set forth above.

	 	 	 	 	 	 	 
	 	 	COMPANY:	 	 
	 	 	BancTrust Financial Group, Inc.	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	/s/ W. Bibb Lamar, Jr.
 

	 	 
	 	 	Name: W. Bibb Lamar, Jr.	 	 
	 	 	
Title: Chief Executive Officer

	 	 
	 
	 	 	 	 	 	 
	 	 	INVESTOR:	 	 
	 	 	YA Global Master SPV Ltd.	 	 
	 
	 	 	 	 	 	 
	 	 	By: Yorkville Advisors, LLC	 	 
	 	 	Its: Investment Manager	 	 
	 
	 

	 	By:
	 	/s/ Gerald Eicke
 

	 	 
	 	 	Name: Gerald Eicke	 	 
	 	 	Title: Managing Member	 	 

28

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00180-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00180-of-00352.parquet"}]]